CLOSE ×
×

    Cell line references

    Tissue sub-type Cell line References Mice Models Rat Models
    Cancer Stem Cells (Human Tissue)
    Adenocarcinoma A549 535 B-NDG
    Adenocarcinoma H1975 535 B-NDG
    Brain BTSC83 200 nude
    Brain Glioblastoma 331, 341, 343, 432 NOD.SCID, nude
    Brain LA-N-5 231 nude
    Brain NGC-407-GFP 206 nude
    Brain U87-SC 232 nude
    Breast 2LMP (MDA-MB-231 subclone) 234 NOD.SCID
    Breast BCM-2147 340, 577 SCID-beige
    Breast BCM-2665 340 SCID-beige
    Breast BCM-3887 340 SCID-beige
    Breast BCM-4195 340 SCID-beige
    Breast MCF-7 (CSC-like) 236 nude
    Breast MCF-7 (mammospheres) 235 nude
    Breast SUM159 234, 629 NOD.SCID, nude
    Breast NMuMG-RFP 486 NOD.SCID
    Breast E1KD-GFP 486 NOD.SCID
    Breast (mammary) LTR-MycER DCIS 482 NOD-SCID
    Colon Colon tumor tissue 428 NOD.SCID
    Gastric GSC1 471 SCID-beige
    Glioma CD133 462 SCID-beige
    Glioma OCT4/SOX2 462 SCID-beige
    Lung A549 108, 501, 573 nude
    Lung H1299 108, 573 nude
    Ovarian A2780-CR5 [ALDH(+) and ALDH(-)] 350 nude
    Ovarian SKOV-3 (spherical cells) 213 BALB/c nude
    Prostate DU-145 (spheroid cells) 233 NOD.SCID
    Human Tissue
    Bladder KU-7 148, 149, 150, 151 nude
    Bladder T24 52, 478, 591 NOD.SCID, nude nude
    Bladder T24- Luc 531 B-NDG
    Bladder UM-UC1 278 nude
    Bladder UM-UC13 278 nude
    Bladder UM-UC3 278 nude
    Bladder RT4 478 NOD.SCID
    Bladder HT-1376 478 NOD.SCID
    Bladder 5637 478 NOD.SCID
    Bladder 5637-Luc 551 B-NDG
    Bladder H157 464 SCID-beige
    Bladder H1299 464 SCID-beige
    Brain A-172 198 nude
    Brain G55 3, 445 nude nude
    Brain GL15 286 C.B-17 SCID
    Brain HTLA-230 5, 125 SCID-beige, nude
    Brain SH-SY5Y 2, 563 nude nude
    Brain TB10 200 nude
    Brain U251 81, 202, 414, 422, 427 nude nude
    Brain U251 MG 198, 199, 550 nude, B-NDG
    Brain U251-NG2 1, 285 nude
    Brain U87 71, 81, 117, 173, 196, 414, 450, 529, 566, 615, 680 NMRI nude, nude, SCID, SCID-beige nude, RAG2 KO(SD)
    Brain U87ΔEGFR 197 nude
    Brain U87MG 4, 78, 80, 83, 133, 134, 164, 195, 198, 201, 205, 206, 209, 224, 249, 342, 404, 427, 550, 596 BALB/c SCID, beige-nude-xid, CD-1 nude, NMRI nude, nude, SCID, B-NDG nude
    Brain U87Fluc 79, 82 BALB/c nude, nude
    Brain U87MG.wt EGFR 203 nude
    Brain U87-TARTK 208 NOD.SCID
    Brain U138MG 203, 266 NOD.SCID, nude
    Brain U373 207 nude
    Brain SH-EP 443 nude
    Brain WAC2 443 nude
    Brain D341 Med 524 nude
    Brain D384 Med 524 nude
    Brain D425 Med 524 nude
    Brain (astrocytoma) U87 528 RAG2 KO(SD)
    Brain (diffuse intrinsic pontine glioma) TT150630 546 B-NDG
    Brain (diffuse intrinsic pontine glioma) TT150728 546 B-NDG
    Breast 231/LM2-4 353 nude
    Breast BT-474 61, 62, 72, 143, 157, 160, 161, 162,163, 165, 211, 227, 228, 258, 270, 601 BALB/c nude, nude, C.B-17 SCID, SCID-beige
    Breast BT-474C 299 nude nude
    Breast BT474-EEI 252, 556 beige-nude-xid
    Breast BT-474-M1 178, 253, 254, 257, 288 beige-nude-xid, nude, SCID
    Breast BT-474/TR 161, 162 nude
    Breast HCC1569 162 nude
    Breast JIMT-1 68, 69, 226, 289 C.B-17 SCID, NMRI nude, nude, SCID
    Breast KPL-4 143, 627, 667 nude, SCID-beige, NOD.SCID
    Breast MCF-7 8, 14, 24, 97, 103, 128, 130, 131, 132, 138, 143, 146, 192, 210, 217, 218, 219, 226, 229, 230, 255, 256, 290, 308, 309, 310, 311, 312, 313, 354, 412, 468, 608, 629 BALB/c nude, CD-1 nude, MF1 nude, nude, SCID, SCID-beige, SHrN® nude
    Breast MCF-GFP 349 nude
    Breast MCF-RSK4 349 nude
    Breast MCF/HER2-18 160 nude
    Breast MDA-MB-175 253 beige-nude-xid
    Breast MDA-MB-231 9, 11, 12, 15, 56, 71, 94, 111, 116, 136, 139, 143, 156, 174, 176, 177, 184, 185, 186, 187, 188, 189, 190, 191, 193, 209, 217, 267, 287, 299, 354, 408, 431, 442, 454, 481, 504, 510, 516, 624, 625, 678 BALB/c SCID, CD-1 nude, nude, NOD.SCID, SCID, SCID-beige, CB-17 nude
    Breast MDA-MB-231-mCherry 282 nude
    Breast MDA-MB-231-Luc 477, 575, 611 NOD.SCID
    Breast MDA-MB-361 60, 256, 313 nude
    Breast MDA-MB-435 12 nude
    Breast MDA-MB-453 158, 256 nude
    Breast MDA-MB-468 226, 260, 266, 421, 581, 667 nude, NOD.SCID, SCID
    Breast MEF-p95-HER2 64 nude
    Breast MT-1 13, 170, 245 CD-1 nude, nude nude
    Breast T47D 6, 7, 130, 210, 229, 259, 310, 313, 402 BALB/c nude, nude, SCID-beige
    Breast ZR-75-1 299, 429 nude, NOD.SCID nude
    Breast BT549 442 nude
    Breast MIV-shSCR 480 NOD.SCID
    Breast MIV-INHBA 480 NOD.SCID
    Breast CACNA1H 500 NOD.SCID
    Breast MCF-7eGFP 515 nude
    Breast MCF-7FGFR1 515 nude
    Breast MCFDCIS 518 nude
    Breast BT-474R2 527 nude
    Cervical HeLa 78, 124, 344, 346, 347, 449 nude nude
    Cervical Hep-2 (HeLa contaminant) 345 BALB/c nude
    Cervical ME-180 291 nude
    Cervical SiHa 291, 588 nude
    Carcinoma HCC95 517 nude
    Carcinoma KYSE-180 517 nude
    Carcinoma CMV-luciferase 552 B-NDG
    Carcinoma Sk-HEP-1 (nano-Luc+) 553 B-NDG
    Colon BCS-TC2.2 113 nude
    Colon Colo201 338 nude
    Colon Colo205 180, 299 nude, NOD.SCID nude
    Colon Colo320 113 nude
    Colon Colo320-CD9 113 nude
    Colon GEO 143, 258, 338 nude, SCID-beige
    Colon HCA-7 17 nude
    Colon HCT-15 338 nude
    Colon LoVo 116, 299 nude nude
    Colon LS174T 63, 140, 159, 392 nude
    Colon MV522 180 nude, NOD.SCID
    Colon SW480 122 SCID
    Colon SW48 509, 604 nude
    Colon LIM1215 509 nude
    Colorectal CX-1 20 nude
    Colorectal DLD-1 16, 152, 243, 294, 651 nude, B-NDG
    Colorectal HCT-116 17, 18, 19, 112, 143, 153, 164, 413, 419, 564, 604 nude, SCID, SCID-beige, B-DNG
    Colorectal HT-29 16, 22, 23, 114, 115, 116, 117, 141, 143, 147, 239, 263, 295, 299, 347, 564, 571 BALB/c nude, beige-nude-xid, NMRI nude, nude, SCID-beige nude
    Colorectal SW620 243, 294, 578 nude
    Endometrial ECC-1 312 nude
    Esophageal FLO-1 172, 559 nude
    Esophageal OE19 126, 127, 138, 154, 175 BALB/c nude, MF1 nude, nude, SCID
    Esophageal OE21 154 nude
    Esophageal OE33 154, 155, 172 nude
    Esophageal OE47 154 nude
    Fibrosarcoma HT1080 77, 124, 209, 406, 607 BALB/c SCID, nude
    Gastric MKN45 124 nude
    Gastric N87 70, 143, 164, 175, 258, 461, 619 NMRI nude, nude, SCID, SCID-beige
    Gastric HS746T 417 nude
    Gastric OE-19 461 SCID-beige
    Gastric JIMT-1 461 SCID-beige
    Gastric RN-87 461 SCID-beige
    Gastric ROE-19 461 SCID-beige
    Gastric SNU-216 461 SCID-beige
    Gastrointestinal GIST-T1 436 SCID-beige
    Glioma H157 464 SCID-beige
    Glioma H1299 464 SCID-beige
    Head & Neck Squamous Cell Carcinoma (HNSCC) Cal-27 65, 66, 67 nude
    Head & Neck Squamous Cell Carcinoma (HNSCC) CCL 23 (HeLa contaminant) 67 nude
    Head & Neck Squamous Cell Carcinoma (HNSCC) FaDu 21, 65, 244, 555, 582 nude nude
    Head & Neck Squamous Cell Carcinoma (HNSCC) HeLa-O3 330 nude
    Head & Neck Squamous Cell Carcinoma (HNSCC) HNX-OE 21 nude
    Head & Neck Squamous Cell Carcinoma (HNSCC) SCC-1 284 nude
    Head & Neck Squamous Cell Carcinoma (HNSCC) UM-SCC1 66, 67, 116, 284 nude
    Head & Neck Squamous Cell Carcinoma (HNSCC) UMSCC38 279 nude
    Head & Neck Squamous Cell Carcinoma (HNSCC) WSUHN-31 60 nude
    Head & Neck Squamous Cell Carcinoma (HNSCC) SE-Pt#1 479 NOD.SCID
    Head & Neck Squamous Cell Carcinoma (HNSCC) SE-Pt#2 479 NOD.SCID
    Head & Neck Squamous Cell Carcinoma (HNSCC) SE-Pt#3 479 NOD.SCID
    Head & Neck Squamous Cell Carcinoma (HNSCC) SE-Pt#4 479 NOD.SCID
    Head & Neck Squamous Cell Carcinoma (HNSCC) SE-Pt#5 479 NOD.SCID
    Head & Neck Squamous Cell Carcinoma (HNSCC) SE-Pt#6 479 NOD.SCID
    Leukemia ARH-77 298 C.B-17 SCID
    Leukemia HEL9217 57 C.B-17 SCID
    Leukemia HL60 57, 171 C.B-17 SCID
    Leukemia HPB-ALL 27 nude
    Leukemia K562 171, 396, 545 C.B-17 SCID, SHrN®, B-NDG
    Leukemia KG-1 144 C.B-17 SCID
    Leukemia MV4-11 166, 179, 180, 181, 182, 296, 348 NOD.SCID, nude nude
    Leukemia TF1-α 57 C.B-17 SCID
    Leukemia THP-1 75 C.B-17 SCID
    Leukemia ERY-1 502 nude
    Leukemia GFP‐labeled Reh PRPS1 547 B-NDG
    Leukemia NALM6 ALL 549 B-NDG
    Leukemia Reh ALL 549 B-NDG
    Leukemia (acute myeloid) RUVBL1/2 465 SCID-beige
    Leukemia (acute myeloid) AML 466 SCID-beige
    Leukemia (acute myeloid) AML1-ETO 512 nude
    Liver AKH10 307 SCID-beige
    Liver Hep3B 25, 101, 119, 137, 222, 223, 225, 392 nude nude
    Liver Hep-G2 122, 548 SCID, B-NDG
    Liver HepT1 25 nude
    Liver HuCCT1 262 nude
    Liver HuH6 26, 411, 415, 506 nude nude
    Liver Huh-7 122 SCID
    Liver KFJ6 307 SCID-beige
    Liver KFJ9 307 SCID-beige
    Liver KFJ10 307 SCID-beige
    Liver COA67 506 nude
    Lung adenocarcinoma H157 464 SCID-beige
    Lung adenocarcinoma H1299 464 SCID-beige
    Lung A549 9, 11, 15, 33, 109, 110, 117, 122, 143, 183, 244, 258, 416, 472, 492, 514, 691 NMRI nude, nude, SCID, SCID-beige, NOD.SCID nude
    Lung A549m 279 nude
    Lung BEN 88 SCID-beige
    Lung Calu6 142, 143, 299, 604 NOD.SCID, SCID-beige, nude nude
    Lung Colo-699 34, 88, 89 SCID-beige
    Lung H226B 279 nude
    Lung H358 31, 595 nude
    Lung KNS-62 34, 88, 89 SCID-beige
    Lung L2987 143 SCID-beige, nude
    Lung LX-1 143 SCID-beige, nude
    Lung NCI-H460 114, 225, 293, 297 C.B-17 SCID, nude nude
    Lung NCI-H69 143, 354, 615 nude, SCID-beige, SHrN®
    Lung NCI-H82 118, 615 nude
    Lung NCI-H841 354 SHrN®
    Lung NCI-N417 32 nude
    Lung PC-9/BRc1 351 nude
    Lung H292 407 nude
    Lung H865 409 nude
    Lung H2122 507 nude
    Lung TC1 Luc 519 nude
    Lymphoma (non-Hodgkin's) DoHH2 435 C.B-17 SCID
    Lymphoma (non-Hodgkin's) Ramos 435, 664, 665 C.B-17 SCID
    Lymphoma (non-Hodgkin's) WSU-DLCL2 435 C.B-17 SCID
    Lymphoma (non-Hodgkin's) Raji 120, 121, 182, 643 NOD.SCID, SCID
    Lymphoma (non-Hodgkin's) L-428 511 nude
    Lymphoma CA46 144 SCID
    Lymphoma Granta 519, 30, 144 SCID
    Lymphoma Karpas-299 28, 90, 542, 654 SCID, B-NDG
    Lymphoma Raji 542, 543, 643, 646 B-NDG
    Lymphoma L540cy 28 SCID
    Lymphoma SP53 30 SCID
    Lymphoma Z138 238 SCID
    Lymphoma Human Lymphoma B (P493) 453 CB-17
    Lymphoma Nalm6 472 SCID-beige
    Lymphoma REC-1 520 nude
    Lymphoma SU-DHL-2 538 B-NDG
    Melanoma 518A2 122, 247, 319, 321 C.B-17 SCID, SCID
    Melanoma 537MEL 323 beige-nude-xid
    Melanoma 607B 247 SCID
    Melanoma A2058 318 SCID
    Melanoma A375 163, 281, 306, 316 nude
    Melanoma A375M 249 nude
    Melanoma DM6 85 nude
    Melanoma FM82 320 NOD.SCID
    Melanoma Ge 248 SCID-beige
    Melanoma Mel-JUSO 247 SCID
    Melanoma MelM9 322 C.B-17 SCID
    Melanoma NIH1286 84 nude
    Melanoma SIT1 37 SCID
    Melanoma SK-MEL23 323 beige-nude-xid
    Melanoma SK-MEL23/155 495 NOD.SCID
    Melanoma UACC 903, 315 nude
    Melanoma VM 317 BALB/c SCID
    Melanoma hCMEC/D3 476 NOD-SCID
    Melanoma SC-1800 476 NOD-SCID
    Melanoma H1 (or H1_DL2) 476 NOD-SCID
    Melanoma H2 476 NOD-SCID
    Mesothelioma DEVy 100 nude
    Mesothelioma shNT-Gpx4 iKO-TGL MSTO-211H 487 NOD.SCID
    Mesothelioma hMerlin-Gpx4 iKO-TGL MSTO-211H 487 NOD-SCID
    Mesothelioma shNT HCT116 525 nude
    Mesothelioma shLats1/2 HCT116 525 nude
    Multiple Myeloma ARP-1 144 SCID
    Multiple Myeloma KAS-6/1 76 SCID
    Multiple Myeloma L-363 120 SCID
    Multiple Myeloma LAGΛ-1 74, 75 nude
    Multiple Myeloma MM.1S 120, 144, 399, 489, 493 C.B-17 SCID, SCID
    Multiple Myeloma MPC-11 325 beige-nude-xid
    Multiple Myeloma NCI-H929 242 NOD.SCID
    Multiple Myeloma RPMI 226, 303, 304, 305 C.B-17 SCID, SCID
    Multiple Myeloma U266 242, 489 NOD.SCID
    Multiple Myeloma RUVBL1/2 465, 508 SCID-beige, nude
    Multiple Myeloma NCI-H929 489, 493 NOD.SCID
    Multiple Myeloma RPMI-8226 489, 669, 670 NOD.SCID
    Multiple Myeloma OPM-2 489 NOD.SCID
    Multiple Myeloma AMO-1 489 NOD.SCID
    Multiple Myeloma JJN3 497 NOD.SCID
    Multiple Myeloma NEK2‐OE KMS11 537, 670 B‐NDG, NOD.SCID
    Neuroblastoma COA3 484, 565 NOD.SCID, nude
    Neuroblastoma COA6 484, 565 NOD.SCID, nude
    Oral 686LN 279 nude
    Oral KB (HeLa contaminant) 299 nude nude
    Osteosarcoma OS-17 433 C.B-17 SCID
    Osteosarcoma 143B 405, 433 C.B-17 SCID
    Ovarian A2780 434 C.B-17 SCID
    Ovarian 1A9 78 nude
    Ovarian 1A9ptx10 78 nude
    Ovarian A2780 143, 350 nude, SCID-beige
    Ovarian CAOV3 87 nude
    Ovarian CD228 143 nude, SCID-beige
    Ovarian HEY 269 nude
    Ovarian MW387 143 nude, SCID-beige
    Ovarian NMP-1 96 nude
    Ovarian OVA-1 91 SCID
    Ovarian OVCAR-3 39, 73, 98, 99, 45, 456, 631, 668 NMRI nude, nude, SCID-beige
    Ovarian OVCAR4 522 nude
    Ovarian OVCAR8 458 SCID-beige
    Ovarian PA354 143 nude, SCID-beige
    Ovarian SKOV-3 38, 40, 41, 55, 86, 92, 93, 95, 211, 212, 213, 214, 292, 324 BALB/c nude, beige-nude-xid, nude, SCID, NOD.SCID nude
    Ovarian SKOV3-luc 237, 446, 632, 642 nude, B-NDG nude
    Ovarian fLuc+ SK-OV-3 539 B-NDG
    Pancreatic AsPC-1 299 nude nude
    Pancreatic BxPC-3 42, 275, 276, 572 nude
    Pancreatic BxPC3/vector 276, 280 nude
    Pancreatic BxPC3/shSTAT3 280 nude
    Pancreatic Bx/shRON 276 nude
    Pancreatic CFPAC-1 43, 394 nude
    Pancreatic Colo357 42, 44, 251 nude, SCID-beige
    Pancreatic HPAC 299 nude nude
    Pancreatic L3.6pl 123, 236 nude
    Pancreatic MIA-Luc 202 nude
    Pancreatic MIA PaCa-2 54, 167, 277, 420, 558,572, 595, 604, 652 nude, B-NDG
    Pancreatic PANC-1 42, 167, 168, 491 ,597 nude, NOD.SCID
    Pancreatic Panc185 272 nude
    Pancreatic Panc89 45 SCID
    Pancreatic Panc430 262 nude
    Pancreatic PL45 43 nude
    Pancreatic T3M4 42 nude
    Prostate CWR22 51, 143, 623 nude, SCID-beige
    Prostate DU-145 29, 211, 221, 679 ICR-SCID, nude, SCID-beige
    Prostate LAPC4 107, 352 nude
    Prostate LNCaP 50, 104, 105, 106, 194, 223, 246, 326, 410, 430, 494, 594, 609, 671 nude, C.B-17 SCID, SCID, NOD.SCID
    Prostate LuCap35 143 nude, SCID-beige
    Prostate MDA-PCa-2b 143 nude, SCID-beige
    Prostate PC-3 46, 47, 48, 49, 129, 135, 138, 143, 169, 209, 211, 216, 220, 240, 246, 283, 302, 513, 562, 594, 596 BALB/c nude, BALB/c SCID, beige-nude-xid, MF1 nude, nude, SCID, SCID-beige
    Prostate PC-3M 164 nude
    Prostate VCaP 215, 513 nude
    Prostate 22Rv1 513, 583 nude
    Prostate C4-2 513, 583 nude
    Prostate ARCaPM 521 nude
    Prostate LNCaP-HSD17B2 541 B-NDG
    Renal 786O 127, 138, 180, 654 BALB/c nude, MF1 nude, NOD.SCID, nude
    Renal ACHN 328 NOD.SCID
    Renal Caki-1 444, 605 nude
    Renal Caki-1 CLDN7-Luc 533 B-NDG
    Renal Caki-2 329 nude
    Renal SK-NEP-1 415 nude
    Renal MRKT 415 nude
    Renal G401 415 nude
    Renal Primary (Immortalized) 439 SCID-beige
    Renal SMMC-7721-luciferase 534 B-NDG
    Retinoblastoma Y79 241 nude
    Sarcoma SK-LMS-1 523 nude
    Skin (HPV16)BC-1-Ep/SL-LF 314 beige-nude-xid, nude, SHrN®
    Skin (benign) Shope papilloma 301 nude
    Skin (Merkel Cell Carcinoma) MCPyV-positive MCC cell lines 483 NOD.SCID
    Squamous-cell/epidermoid carcinoma A431 143, 211, 262, 264, 265, 266, 267, 268, 412 NOD.SCID, nude, SCID-beige
    Testicular NCCIT 53 nude
    Thyroid CAL62 496 NOD.SCID
    Thyroid CAL62-splice cells 496 NOD.SCID
    Thyroid H1299 464 SCID-beige
    Thyroid H157 464 SCID-beige
    Uveal melanoma M619 102 SCID
    Uveal melanoma MUM2B 102 SCID
    Uveal melanoma OCM1a 102 SCID
    Vulva A431 327, 345 BALB/c nude, NOD.SCID
    Vulva SK-LMS-1 145 nude
    Colon LS411N 392 nude
    Colon SW403 392 nude
    Pancreatic CFPAC-1 394 nude
    Lung H226 (NSCLC) 395 nude
    Head & Neck Squamous Cell Carcinoma (HNSCC) SCC1483 395 nude
    Head & Neck Squamous Cell Carcinoma (HNSCC) SCC1 (cetuximab-resistant) 395 nude
    Brain GS-11 397 SHrN®
    Lymphoma MUTU-1 398 C.B-17 SCID
    Brain T87 GSC 400, 425 nude
    Breast MDA-IBC3 401 SCID-beige
    Breast SUM149 401 SCID-beige
    Head & Neck Squamous Cell Carcinoma (HNSCC) Cal33 555 nude
    Prostate PC3M-Luc 560 nude
    Breast GPX4 iKO BT474 562 nude
    Head and neck, breast PDX 567 nude
    Brain IMR32 568 nude
    Lung Cancer HCC827 HCC827-ER1 570 nude
    Pancreatic PANC-1-luc 572 nude
    Ovarian PDX 574, 672, 684 nude
    Lymphoma SUP-T1-luc 576 nude
    Breast shOBR-MCF-7 579 nude
    Breast shOBR MDA-MB-231 579 nude
    Ovarian ES2 580 nude
    Breast AU565 581 nude
    Adrenal H295R 584 nude
    Lung A549-Red-FLuc Bioware® Brite Cell Line 585 nude
    Lung A549shHTATIP2 586 nude
    Lung A549-luc 587, 645 nude, NOD.CB17-Prkdcscid IL2rgtm1/BcgenHsd
    Glioblastoma G9pCDH-copGFP 590 nude
    Bladder J82-Ras 591 nude
    Prostate PC3 560 nude
    Prostate PAC120 594 nude
    Prostate CDX 594 nude
    Glioblastoma NCH421K 596 nude
    Glioblastoma P13 596 nude
    Glioblastoma P3-stem cell-like 596 nude
    Glioblastoma P22 596 nude
    Glioblastoma DBTRG-shCtr, DBTRG-shΔNp73 598 nude
    Glioblastoma SJGBM2-Ctr, SJGBM2-ΔNp73 598 nude
    Glioblastoma SJGBM2-luc 598 nude
    Glioblastoma CHLA-200 598 nude
    Neuroblastoma SK-N-BE(2)  600 nude
    Ovarian OV90-KRCCshRNA, OC90-ctrl 603 nude
    Melanoma SK-MEL30 604 nude
    Colon KM-12 606 nude
    Breast MDA-MB-231-shFBXO44 611 nude
    Ovarian OV8-mcherry 612 nude
    Pancreatic Panc354 614 nude
    Brain U87-CXCR4 615 nude
    Lymphoma (PCNSL-primary CNS lymphona) PCNSL-5 615 nude
    Lymphoma (PCNSL-primary CNS lymphona) PCNSL-6 615 nude
    Lymphoma (PCNSL-primary CNS lymphona) PCNSL-10 615 nude
    Lymphoma (PCNSL-primary CNS lymphona) PCNSL-11 615 nude
    Lymphoma (PCNSL-primary CNS lymphona) PCNSL-12 615 nude
    Lymphoma (PCNSL-primary CNS lymphona) PCNSL-14 615 nude
    Lymphoma (PCNSL-primary CNS lymphona) PCNSL-15 615 nude
    Lymphoma (PCNSL-primary CNS lymphona) PCNSL-16 615 nude
    Lymphoma (PCNSL-primary CNS lymphona) PCNSL-14 615 nude
    Lymphoma (PCNSL-primary CNS lymphona) PCNSL-14 615 nude
    Breast MDA-MB-231-shYBX1 616 nude
    Breast MDA-MB-231-GFP 617 nude
    Kidney HEK-SST2 618, 621 nude
    Kidney HEK-SST5 618, 621 nude
    Oral squamous cell carcinoma HSC-3 GFP/Luc 620 nude
    Glioma BT3 622 nude
    Prostate CWR22-MEIS1 623 nude
    Prostate CWR22-HOXB13ko 623 nude
    Prostate CWR22-HOXB13ko 623 nude
    Breast SK-BR3 630, 665 nude, C.B-17 SCID
    Glioma HSJD-DIPG-007 633 nude
    Lung NCI-H441 643 B-NDG
    Hematopoetic iTregs 647 B-NDG
    Multiple Myeloma U266-GFP-Luc 649 B-NDG
    Colorectal DLD-1-HDAC2 KO 651 B-NDG
    Colorectal DLD-1-HDAC2 KO-shH19 651 B-NDG
    Colorectal DLD-1-HDAC2 KO-shH19 651 B-NDG
    Pancreatic S2VP10 655 C.B-17 SCID
    Pancreatic S2CP9 655 C.B-17 SCID
    Multiple Myeloma MM.1S-Luc 656 C.B-17 SCID
    Ovarian KRCH31 660 C.B-17 SCID
    Ovarian SARARK9 661 C.B-17 SCID
    Uterine serous carcinoma ARK2 663 C.B-17 SCID
    Uterine serous carcinoma CCL-155 664 C.B-17 SCID
    Teratoma Multipotent mesenchymal stromal cells (MSC) 674 NOD.SCID
    Thyroid THJ‐16T 676 R2G2®
    Leukemia MEC-2 677 R2G2®
    Multiple Myeloma MM.1S-GFP 686 SCID-beige
    Leukemia HMC1.1 688 SCID-beige
    Leukemia HMC1.2 688 SCID-beige
    Leukemia RPMI 8666 688 SCID-beige
    Patient-Derived Tumors (Human Tissue)
    Breast WHIM18 (luminal) 689 SCID-beige
    Breast WHIM20 (luminal) 689 SCID-beige
    Brain (PDX) 271, 426, 626, 662 nude, C.B-17 SCID nude
    Brain U87MG (GBM PDX) 337 nude
    Breast BMC-2147 274 SCID-beige
    Breast HBCX 1 270 nude
    Breast HBCX 6 270 nude
    Breast HBCX 7 270 nude
    Breast HBCX 9 270 nude
    Breast HBCX 12B 270 nude
    Breast HBCX 17 270 nude
    Breast HBCx-3 339 BALB/c nude
    Breast HBCx-4A 339 BALB/c nude
    Breast HBCx-8 339 BALB/c nude
    Breast HBCx-24 339 BALB/c nude
    Breast HBCx-30 339 BALB/c nude
    Breast PDX60 349 NMRI nude
    Breast PDX156 349 NMRI nude
    Breast MC1 274, 683 SCID-beige
    Breast TNBC (MC1) 273 NOD.SCID
    Breast BCM-2147 440, 577, 683 SCID-beige, nude
    Breast BCM-4013 440, 577, 683 SCID-beige, nude
    Breast BCM-4888 469, 683 SCID-beige
    Breast BCM-4272 469, 683 SCID-beige
    Breast BCM-3887 469, 683 SCID-beige
    Breast SUM149 441 SCID-beige
    Breast HCI-001 442 NOD.SCID
    Breast HCI-010 442 NOD.SCID
    Breast HMEC 455 SCID-beige
    Breast A73 473 SCID-beige
    Breast E0771 473 SCID-beige
    Breast E0771-ICBR 473 SCID-beige
    Breast PyMT-M 473 SCID-beige
    Breast PyMT-N 473 SCID-beige
    Breast PyMT-M-ICBR 473 SCID-beige
    Breast PDX-1079 474 CB-17
    Breast PDX-9327 474 CB-17
    Breast PDX-1173 474 CB-17
    Breast SUM149PT 499 NOD.SCID
    Breast HCC1428 499 NOD.SCID
    Breast MDAMB468 499 NOD.SCID
    Breast ZR751 499 NOD.SCID
    Breast PDX PT1-17 503 nude
    Breast MCF7 526 nude
    Breast HIM3 526 nude
    Carcinoma (Intrahepatic cholangiocarcinoma) PDX0044 (ICC PDX) 540 B-NDG
    Colorectal (BRAF mutant PDX) 332 NMRI nude
    Colorectal (KRAS mutant PDX) 332 NMRI nude
    Colorectal (PIK3CA mutant PDX) 332 NMRI nude
    Colorectal (PTEN mutant PDX) 332 NMRI nude
    Colorectal CUCRC006 338 nude
    Colorectal CUCRC026 338 nude
    Colorectal CUCRC036 338 nude
    Colorectal CUCRC042 338 nude
    Colorectal CUCRC047 338 nude
    Colorectal CUCRC040 (KRAS mutant PDX) 336 nude
    Colorectal CUCRC042 (KRAS/PIK3CA mutant PDX) 336 nude
    Colorectal CUCRC108 (KRAS mutant PDX) 336 nude
    Colorectal CUCRC125 336 nude
    Colorectal PDX 530 B-NDG
    Glioblastoma GMB-05 475 NOD.SCID
    Glioblastoma GMB-06 475 NOD.SCID
    Glioblastoma GMB-07 475 NOD.SCID
    Glioma GMB-derived 485 NOD.SCID
    Head & Neck Squamous Cell Carcinoma (HNSCC) PDX-SE1 490 NOD.SCID
    Head & Neck Squamous Cell Carcinoma (HNSCC) PDX-SE3 490 NOD.SCID
    Liver AKH23 307 SCID-beige
    Liver KFJ18 307 SCID-beige
    Lung (NSCLC PDX) 272, 624 NOD.SCID, nude
    Lung (SCLC PDX) 536, 544 B-NDG
    Lung p2 SCLC PDXact 354 NOD.SCID
    Melanoma H1 488 NOD.SCID
    Melanoma H2 488 NOD.SCID
    Melanoma H3 488 NOD.SCID
    Melanoma H10 488 NOD.SCID
    Neuroblastoma SK-N-SH 451 CB-17
    Ovarian (ovarian, primary peritoneal, or fallopian tube cancer PDX) 437, 438, 681 SCID-beige, nude
    Ovarian PAPP-A 457 SCID-beige
    Ovarian OVCAR-8 460 SCID-beige
    Ovarian PH026 467, 690 SCID-beige
    Ovarian PH048 467 SCID-beige
    Ovarian PH212 467 SCID-beige
    Pancreatic JH033 272 nude
    Pancreatic Panc194 335 nude
    Prostate KRAS PANC-1 459 SCID-beige
    Prostate 1B 333 nude
    Prostate 2B 333 nude
    Prostate 2T 333 nude
    Prostate 3B 333 nude
    Prostate 3T 333 nude
    Prostate 4B 333 nude
    Prostate 4T 333 nude
    Prostate LuCaP35CR 410 nude
    Prostate C4-2B 452 CB-17
    Prostate DU145 452 CB-17
    Prostate C4-2B-TaxR 452 CB-17
    Prostate DU145-TaxR 452 CB-17
    Sarcoma (Chondrosarcoma PDX) 334 nude, C.B-17 SCID
    Sarcoma (Ewing sarcoma PDX) 334, 662 nude
    Sarcoma (Leiomyosarcoma PDX) 334 nude
    Sarcoma (Liposarcoma PDX) 334 nude
    Sarcoma (Multifocal sarcoma PDX) 334 nude
    Sarcoma (Myxoma PDX) 334 nude
    Sarcoma (Phyllodes sarcoma PDX) 334 nude
    Sarcoma (Rhabdomyosarcoma PDX) 334, 662 nude, C.B-17 SCID
    Sarcoma (Small round cell sarcoma PDX) 334 nude
    Sarcoma (Spindle cell sarcoma PDX) 334 nude
    Sarcoma (Synovial sarcoma PDX) 334 nude
    Kidney (Renal Cell Carcinoma PDX) 393 nude
    Oral (Floor of Mouth Squamous Cell Carcinoma PDX) 395 nude
    Thyroid BCPAP 448 nude
    Thyroid TPC-1 448, 463, 628 SCID-beige, nude nude
    Thyroid CUTC5 470, 505 SCID-beige, nude
    Thyroid CUTC48 470, 505 SCID-beige, nude
    Thyroid CUTC60 470, 505 SCID-beige, nude
    Thyroid CUTC61 470, 505 SCID-beige, nude
    Breast BCM-2277 577 nude
    Prostate LuCaP-23.1 583 nude
    Pancreatic PC13 589 nude
    Glioblastoma GBM143 592 nude
    Neuroblastoma PC9GR 602 nude
    Lung PC9GROR 602 nude
    Ovarian OVCAR-5 610 nude
    Pancreatic PDX 613 nude
    Esophageal squamous cell carcinoma PDX 650 B-NDG
    Brain GBM38-Luc-GFP 657 C.B-17 SCID
    Brain 15-037 (GBM PDX) 658 C.B-17 SCID
    Breast TNBC (KRAS WTPDX) 659 C.B-17 SCID
    Prostate (PDX) 675 NOD.SCID
    Endometrial (PDX) 681 SCID-beige
    Breast BCM-4664 683 SCID-beige
    Breast HCI-002 683 SCID-beige
    Breast BCM-5471 683 SCID-beige
    Breast BCM-2665 683 SCID-beige
    Breast BCM-3204 683 SCID-beige
    Breast BCM-3107 683 SCID-beige
    Breast HMCC-3186 683 SCID-beige
    Breast BCM-3936 683 SCID-beige
    Breast BCM-4913 683 SCID-beige
    Breast HMCC-3555 683 SCID-beige
    Ovarian PM-LGSOC-01 684 SCID-beige
    Breast WHIM16 685 SCID-beige
    Ovarian PH450 687 SCID-beige
    Ovarian PH578 687 SCID-beige
    Breast WHIM2 (basal-like) 689 SCID-beige
    Breast WHIM14 (basal-like) 689 SCID-beige
    Rodent Tissue
    Bladder (rat) NBT-II 299 nude nude
    Bladder AY-27 357 Fischer 344
    Brain RT2-GFP 356 Fischer 344
    Brain Tu-2449 365 B6C3F1
    Brain (murine glioblastoma) GL-261 424 C57BL/6
    Brain (murine glioma) RG2 528 RAG2 KO(SD)
    Brain (rat glioma) C6 58, 59, 78, 140, 180 NOD.SCID, nude
    Breast 4T1-luc2 366, 423, 634 BALB/c
    Breast 4T1 379, 381, 382, 390, 473, 477, 627, 635, 636, 637, 639, 640 BALB/c, SCID-beige, NOD.SCID
    Breast T11 473 SCID-beige
    Breast 67NR 473 SCID-beige
    Breast JC 384 C57BL/6J, BALB/c
    Breast MMTV-PyMT 418, 673 nude, NOD.SCID
    Breast P53-null MECs 390 BALB/c
    Breast 4T07 403, 473 BALB/c, SCID-beige
    Carcinoma B4B8 388 BALB/c
    Carcinoma LY2 388 BALB/c
    Carcinoma (murine mammary) 4T1 472 SCID-beige, BALB/c
    Carcinoma (murine) LL/2 472 SCID-beige
    Carcinoma (murine) KIL C.2 532 B-NDG
    Colon AOM-induced colon tumors 358, 359, 364 Fischer 344
    Colon CT26 367, 369, 380, 383, 386, 391, 635, 638, 639 C57BL/6, BALB/c
    Colon CT26CL25 385 BALB/c
    Colon CT26 391 BALB/c
    Colon C51 mouse colon cancer cells 447 nude
    Colorectal AOM-induced colon tumors 362 Fischer 344
    Embryo (murine) Src3T3 299 nude nude
    Esophageal NMBA-induced esophageal tumors 360, 361 Fischer 344
    Liver MC38-Luc1 387 C57BL/6
    Lung (murine) LL2 10 nude
    Lung Cancer LL 371 C57BL/6
    Lymphoma EL4 367, 371 C57BL/6, BALB/c
    Lymphoma E.G7-OVA 373 C57BL/6
    Lymphoma E.G7 384 C57BL/6J, BALB/c
    Mammary MNU-induced mammary tumors 363 Sprague Dawley
    Mammary (rat) DMBA-induced rat mammary carcinoma 301 nude
    Mammary (rat) 17β-estradiol-induced mammary tumors 355 Brown Norway
    Melanoma B16 367, 369, 378, 456 C57BL/6, BALB/c, SCID-beige
    Melanoma RBE4 476 NOD.SCID
    Melanoma B16-F10 368, 370 C57BL/6
    Melanoma B16-OVA 372, 375 C57BL/6
    Melanoma B16.OVA 373 C57BL/6
    Melanoma B16.F10 375 C57BL/6
    Melanoma (murine) B16F10 35, 36, 250, 392 beige-nude-xid, nude
    Oral (murine) PCI-13 498 NOD.SCID
    Ovarian (rat) PROb 78 nude
    Pancreatic Panc02 367, 374, 377 C57BL/6, BALB/c
    Prostate Tgfbr2floxE2 376 C57BL/6
    Oral (murine) MmuPV1 (papilloma virus) 554 nude
    Breast MMTV-PyMT/RANK-/- 557 nude
    Fibrosarcoma MCA205 561, 593, 599 nude
    Pancreatic Atmfl/fl; LSL-KrasG12D/+; Ptf1aCre/+ (AKC) cells 569 nude
    Glioblastoma WT-GBM 596 nude
    Fibrosarcoma MCA205-luc 599 nude
    Lymphoctye (pro-B cell) Ba/F3 606 nude
    Ovarian ID8 610 nude
    Glioma BT4C 622 nude
    Breast EMT6-LUC 634 BALB/c
    Breast 4T1-mCH 639 BALB/c
    Mouse mammary adenocarcinoma TS/A 641 BALB/c
    Mouse embryonic stem cells induced hematopoietic endothelial cells (iHECs)  648 B-NDG
    Fibrosarcoma NIH3T3 ETV6-NTRK3 653 C.B-17 SCID
    Oral (murine) MmuPV1 (papilloma virus) 666 nude
    Breast EMT6 673 NOD.SCID
    Mouse mammary adenocarcinoma AT3 682 SCID-beige
    Canine Tissue
    Prostate Ace-1 449 nude
    Melanoma MDCK 476 NOD.SCID
    Melanoma MDCK-II 476 NOD.SCID


    References

    1. Verhoef, J.J.C. et al., Radiat Oncol, 2, 38 (2007). Netherlands (athymic nude mice )
    2. Ponthan, F. et al., Oncol Reports, 10, 1587 (2003). Netherlands (athymic nude rats)
    3. Rubenstein, J.L. et al., Neoplasia, 2(4), 306 (2000). North America (athymic nude rats)
    4. Plunkett, R.J. et al., J Neurosurg, 90, 1071 (1999). North America (athymic nude rats)
    5. Brignole, C. et al., J Natl Cancer Inst, 96, 1171 (2004). Italy (athymic nude mice, SCID-beige mice)
    6. Pan, Y. et al., Breast Cancer Res, 8, R63 (2006). North America (athymic nude mice)
    7. Sartorius, C.A. et al., Cancer Res, 65(21), 9779 (2005). North America (athymic nude mice)
    8. Arteaga, C.L. et al., Cell Growth & Diff, 4, 193 (1993). North America (athymic nude mice)
    9. Hardman, E.W. et al., Cancer Cell Intl, 2, 10 (2002). North America (athymic nude mice)
    10. Amiekhosravi, A. et al., Thromb Haemost, 90, 549 (2003). North America (athymic nude mice)
    11. Dikmen, Z.G. et al., Turk J Med Sci, 35, 65 (2005). North America (athymic nude mice )
    12. Richert, M.M. et al., Breast Cancer Res, 7, R819 (2005). North America (athymic nude mice)
    13. Burch, S. et al., J Biomedical Optics, 10, 034011-1-13 (2005). North America (athymic nude rats)
    14. Blask, D.E. et al., Breast Cancer Res, And Treatment 79, 313 (2003). North America (athymic nude rats)
    15. Bäuerle, T. et al., Intl J Oncol, 28, 573 (2006). Germany (athymic nude rats)
    16. Prewett, M.C. et al., Clin Cancer Res, 8, 994 (2002). North America (athymic nude mice)
    17. Sheng, H. et al., J Clin Invest, 99, 2254 (1997). North America (athymic nude mice )
    18. Yang, M. et al., Proc Nat Acad Sci, 102, 6027 (2005). North America (athymic nude mice )
    19. Park, B.H. et al., Proc Natl Acad Sci, 98, 2598 (2001). North America (athymic nude mice )
    20. Kruskal, J.B. et al., Radiology, 215, 852 (2000). North America (athymic nude mice)
    21. Tijink, B.M. et al., J Nucl Med, 47, 1127 (2006). EU (athymic nude mice)
    22. Marchal, F. et al., Oncology Reports, 14, 1203 (2005). France (athymic nude rats)
    23. Wang, M. et al., World J Gastroenterol, 9(11), 2627 (2003). France (athymic nude rats)
    24. Dauchy, R. T. et al., Cancer Letters, 209, 7 (2004). North America (athymic nude rats)
    25. Svechnikova, I. et al., Intl J Oncol, 22, 579 (2003). Netherlands (athymic nude rats)
    26. Till, H. et al., Surgical Endoscopy, 19, 1483 (2005). Germany (athymic nude rats)
    27. Barone, T.A. et al., Blood, 90, 298 (1997). North America (athymic nude rats)
    28. Francisco, J.A. et al., Blood, 102, 1458 (2003). North America (SCID mice)
    29. Geldhof, A.B. et al., Clin & Experimental Metastasis, 16(5), 447 (1998). North America (ICR-SCID mice)
    30. Wang, M. et al., Blood, 109, 5455 (2007). North America (SCID mice)
    31. Zou, Y. et al., J Natl Cancer Inst, 90, 1130 (1998). North America (athymic nude mice)
    32. Maneckjee, R. and Minna, J.D., Proc Natl Acad Sci, 89, 1169 (1992). North America (athymic nude mice)
    33. Weinberg, O.K. et al., Cancer Res, 65, 11287 (2005). North America (athymic nude mice)
    34. Boehle, A.S. et al., Intl J Cancer, 94, 420 (2001). Germany (SCID-beige mice)
    35. Horton, H.M. et al., Proc Natl Acad Sci, 96, 1553 (1999). North America (athymic nude mice, beige-nude-xid mice)
    36. Malafa, M.P. et al., Annals of Surgical Oncol, 9(10), 1023 (2002). North America (athymic nude mice)
    37. Bromberg, M.E. et al., Proc Natl Acad Sci, USA 92, 8205 (1995). North America (SCID mice)
    38. Modesitt, S.C. et al., Clin Cancer Res, 7,1487 (2001). North America (athymic nude mice)
    39. Duyndam, M.C.A. et al., Am J Pathol, 160, 537 (2002). Netherlands (athymic nude mice)
    40. Gossmann, A. et al., J Obstetrics and Gynecol, 183, 956 (2000). North America (athymic nude rats)
    41. Mahasreshti, P.J. et al., Clin Cancer Res, 7, 2057 (2001). North America (SCID mice)
    42. Fukasawa, M. and Murray, K., Clin Cancer Res, 10, 3327 (2004). North America (athymic nude mice)
    43. Koehler, J.A. and Drucker, D.J., Diabetes, 55, 1369 (2006). North America (athymic nude mice)
    44. Weber, D. et al., Cancer Res, 60, 5284 (2000). North America (athymic nude mice)
    45. Boenicke, L. et al., J Mol Med, 81, 205 (2003). Germany (SCID mice)
    46. Zhang, X. et al., J Nucl Med, 47, 492 (2006). North America (athymic nude mice)
    47. Tuomela, J.M. et al., BMC Cancer, 8, 81 (2008). Germany (athymic nude mice)
    48. Srivastava, S.K. et al., Carcinogenesis, 24(10), 1665 (2003). North America (athymic nude mice)
    49. Hillman, G.G. et al., Mol Cancer Ther, 3, 1271 (2004). North America (athymic nude mice)
    50. Graff, J.R. et al., J Biol Chem, 275, 24500 (2000). North America (athymic nude mice)
    51. Gregory, C.W. et al., Cancer Res, 61, 2892 (2001). North America (athymic nude mice)
    52. Cabrera, G. et al., Mol Cancer, 5, 32 doi:10.1186/1476-4598-5-32 (2006). North America (athymic nude rats)
    53. Adkins, H.B. et al., J Clin Invest, 112, 575 (2003). North America (athymic nude mice)
    54. Weydert, C. et al., Mol Cancer Ther, 2, 361 (2003). North America (athymic nude mice)
    55. Fu, X, Tao, L and Zhang, X., Cancer Gene Therapy, 14, 480 (2007). North America (athymic nude mice)
    56. Sun, L. and Chen, C., J Biol Chem, 272(40), 25367 (1997). North America (athymic nude mice)
    57. Sutherland, M.K. et al., mAbs 1(5), 481 (2009). North America (SCID mice)
    58. Lai, C.P.K. et al., Cancer Res, 67(4), 1545 (2007). North America (athymic nude mice)
    59. Folkins, C. et al., Cancer Res, 69(18), 7243 (2009). North America (athymic nude mice)
    60. Ueno, N.T. et al., Cancer Res, 62, 6712 (2002). North America (athymic nude mice)
    61. agata, Y. et al., Cancer Cell, 6, 117 (2004). North America (athymic nude mice )
    62. Puig, T. et al., Clin. Cancer Res., 15, 7608 (2009). UK (BALB/c nude mice )
    63. Liu, Z. et al., Nano Res, 3(3), 222 (2010). North America (athymic nude mice)
    64. Chandarlapaty, S. et al., Oncogene, 29, 325 (2010). EU (athymic nude mice)
    65. Simons, A.L. et al., Int J Radiat Oncol Biol Phys, 69(4), 1222 (2007). North America (athymic nude mice)
    66. Want, D. et al., Clin Cancer Res, 14(19), 6228 (2008). North America (athymic nude mice)
    67. LoTempio, M.M. et al., Clin Cancer Res, 11(19), 6994 (2005). North America (athymic nude mice)
    68. Barok, M. et al., Mol Cancer Ther, 6(7), 2065 (2007). Netherlands (NMRI nude mice, SCID mice)
    69. Tanner, M. et al., Mol Cancer Ther, 3(12), 1585 (2004). Netherlands (NMRI nude mice)
    70. Tanner, M. et al., Annals of Oncol, 16, 273 (2005). Netherlands (NMRI nude mice)
    71. Lin, L. et al., Neoplasia, 12(1), 39 (2010). North America (athymic nude mice)
    72. Moulder, S.L. et al., Cancer Res, 61, 8887 (2001). North America (athymic nude mice)
    73. Zhang, X. et al., Clin Cancer Res, 11, 323 (2005). North America (athymic nude mice)
    74. Campbell, R.A. et al., Int J Oncol, 28(6), 1409 (2006). North America (athymic nude mice)
    75. Chen, H. et al., Blood, 113, 1992 (2009). North America (athymic nude mice)
    76. Dingli, D. et al., Clin Cancer Res, 8, 3948 (2002). North America (SCID mice)
    77. Chavez-Blanco, A. et al., Cancer Cell Int, 6, 2 (2006). North America (athymic nude mice)
    78. Ferretti, S. et al., Neoplasia, 11(9), 874 (2009). EU (athymic nude mice)
    79. Heikkilä, J.E. et al., PLoS ONE, 5(1), e8603 (2010). UK (BALB/c nude mice)
    80. Xiao, W. et al., Eur J Nucl Med Mol Imaging, 36, 94 (2009). North America (athymic nude mice)
    81. Li, L. et al., Clin Cancer Res, 13(7), 2178 (2007). North America (athymic nude mice)
    82. Hsu, A.R. et al., J Nucl Med, 48, 445 (2007). North America (athymic nude mice)
    83. Chen, X. et al., J Nucl Med, 45, 1776 (2004). North America (athymic nude mice)
    84. Menon, C. et al., Am J Physiol Heart Circ Physiol, 24, H317 (2003). North America (athymic nude mice)
    85. Ueno, T. et al., Mol Cancer Ther, 5(3), 732 (2006). North America (athymic nude rats)
    86. Goyeneche, A.A. et al., Clin Cancer Res, 13(11), 3370 (2007). North America (athymic nude mice)
    87. Li, D. et al., Oncogene, 21, 2805 (2002). North America (athymic nude mice)
    88. Boehle, A.S. et al., Ann Thorac Surg, 69, 1010 (2000). Germany (SCID-beige mice)
    89. Kurdow, R. et al., Ann Thorac Surg, 73, 905 (2002). Germany (SCID-beige mice)
    90. Hamblett, K.J. et al., Clin Cancer Res, 10, 7063 (2004). North America (SCID mice)
    91. Santin, A.D. et al., Cancer Res, 65(10), 4334 (2005). North America (SCID mice)
    92. Nilsson, M.B. et al., J Biol Chem, 282(41), 29919 (2007). North America (SCID mice)
    93. Spaeth, E.L. et al., PloS ONE, 4(4), e4992 (2009). North America (SCID mice)
    94. Bruckheimer, E.M. et al., Neoplasia, 11(6), 509 (2009). North America (SCID mice, NOD.SCID mice)
    95. Nagengast, W.B. et al., J Nucl Med, 48, 1313 (2007). Netherlands (athymic nude mice)
    96. Auzenne, E. et al., Neoplasia, 9(6), 479 (2007). North America (athymic nude mice)
    97. Rodrigues-Ferreira, S. et al., PLoS ONE, 4(10), e7239 (2009). UK (SCID mice)
    98. Houba, P.H.J. et al., British J Cancer, 78(12), 1600 (1998). Netherlands (athymic nude mice)
    99. Vingerhoeds, M.H. et al., British J Cancer, 74, 1023 (1996). Netherlands (NMRI nude mice)
    100. Le Pimpec-Barthes, F. et al., British J Cancer, 81(8), 1344 (1999). EU (athymic nude rats)
    101. Fu, X. et al., Mol Ther, 7(6), 748 (2003). North America (athymic nude mice)
    102. Folberg, R. et al., Invest Ophthalmol Vis Sci, 48(7), 2967 (2007). North America (SCID mice)
    103. Swami S., et.al., Horm Cancer. 2011 June 1; 2(3): 190-202. North America (athymic nude mice)
    104. Kiyama, S. et al., Cancer Res, 63, 3575 (2003). North America (athymic nude mice)
    105. Elsadek, B. et al., Prostate Cancer and Prostatic Diseases, 14, 14 (2011). Germany (SCID mice)
    106. Sun, S. et al., J Clin Invest, 120(8), 2715 (2010). North America (athymic nude mice)
    107. Li, T.H. et al., Nucleic Acids Res, 35(8), 2767 (2007). North America (athymic nude mice)
    108. Pan, J. et al., PLoS ONE, 5(10), e13298. doi:10.1371/journal.pone.0013298 (2010). North America (athymic nude mice)
    109. Määttä, A.-M. et al., Int J Cancer, 121, 863 (2007). Netherlands (NMRI nude mice)
    110. Jarzynka, M.J. et al., Int J Oncol, 28(2), 337 (2006). North America (athymic nude mice)
    111. Bruckheimer, E.M. et al., Neoplasia, 11(6), 509 (2009). North America (athymic nude mice, SCID mice, NOD.SCID mice)
    112. Yi, J. M. et al., Cancer Res, 68(19), 8094 (2008). North America (SCID mice)
    113. Ovalle, S. et al., Int J Cancer, 121, 2140 (2007). Spain (athymic nude mice )
    114. Schleup, T. et al., Clin Cancer Res, 15, 181 (2009). North America (athymic nude mice )
    115. Orian-Rousseau, V. et al., Int J Cancer, 113, 699 (2005). Germany (SCID-beige mice)
    116. Zielske, S.P. et al., Int J Radiat Oncol Biol Phys, 75(3), 843 (2009). North America (athymic nude mice)
    117. Kaafarani, I. et al., FASEBJ, 23, doi: 10.1096/fj.08-127852 (2009). France (NMRI nude mice)
    118. Koskimaki, J. E. et al., BMC Cancer, 10, 29 (2010). North America (athymic nude mice)
    119. Jakubezak, J.L. et al., Cancer Res, 63, 1490 (2003). North America (athymic nude mice)
    120. McEarchern, J.A. et al., Clin Cancer Res, 14, 7763 (2008). North America (SCID mice)
    121. Kelley, S.K. et al., Br J Pharmacol, 148(8), 1116 (2006). North America (SCID mice)
    122. Smrekar, B. et al., Gene Therapy, 10, 1079 (2003). UK; Germany (SCID mice)
    123. Tremmel, M. et al., Blood, 114(25), 5236 (2009). Germany (athymic nude mice)
    124. Cuesta, Á.M., et al., PLoS ONE, 4(4), e5381. doi:10.1371/journal.pone.0005381 (2009). Spain (athymic nude mice)
    125. Pastorino, F. et al., Cancer Res, 63, 86 (2003). Italy (athymic nude mice )
    126. Kelly, P. et al., British J Cancer, 103, 232 (2010). UK (SCID mice)
    127. Larkin, J.O. et al., Ultrasound Med Biol, 34(3), 406 (2008). UK (MF1 nude mice)
    128. Kang, K.S., et al., PLoS ONE 5(4): e10296. doi:10.1371/journal.pone.0010296 (2010). North America (athymic nude mice)
    129. Shah, G.V. et al., Endocrine-Related Cancer, 15, 953 (2008). North America (athymic nude mice)
    130. Lipnik, K. et al., Virol, 349, 121 (2006). Germany (SCID-beige mice)
    131. Agu, C.A. et al., J Gene Med, 8, 229 (2006). Germany (SCID-beige mice)
    132. Rhodes, L.V. et al., Breast Cancer Res Treat, 121(2), 293 (2010). North America (SCID-beige mice)
    133. Barone, T.A. et al., J Neuro-Oncol, 95(1), 37 (2009). North America (athymic nude rats)
    134. Nanda, D. et al., Cancer Res, 61, 8743 (2001). UK (beige-nude-xid mice)
    135. Markaverich, B. et al., Eviron Health Perspect,110, 169 (2002). North America (athymic nude mice)
    136. Stan, S.D. et al., Cancer Res, 68(18), 7661 (2008). North America (athymic nude mice)
    137. Shashkova, E.V. et al., Cancer Res, 68, 5896 (2008). North America (athymic nude mice)
    138. Larkin, J.O. et al., Ann Surg, 245(3), 469 (2007). UK (BALB/c nude mice, MF1 nude mice)
    139. Loebinger, M.R. et al., Cancer Res, 69(23), 8862 (2009). UK (NOD.SCID mice)
    140. Cai, W. et al., J Nucl Med, 48, 304 (2007). North America (athymic nude mice)
    141. Squires, M.S. et al., Mol Cancer, 8(2), 324 (2009). UK (BALB/c nude mice)
    142. Airoldi, I. et al., PLoS ONE, 4(7), e6119. doi:10.1371/journal.pone.0006119 (2009). Italy (NOD.SCID mice)
    143. Lee, F.Y.F. et al., Cancer Chemother Pharmacol, 63, 201 (2009). North America (athymic nude mice, SCID-beige mice)
    144. Yang, J. et al., Cancer Cell, 10, 295 (2006). North America (SCID mice)
    145. Dauchy, R.T. et al., J Pineal Res, 47, 32 (2009). North America (athymic nude rat)
    146. Wu, J. et al., Cancer Res, 71, 2622 (2011). North America (athymic nude rat)
    147. Sharma, S. et al., Ejc Supplements, ISSN:13596349, 8(7), 66 (2010). North America (athymic nude mice)
    148. Hadaschik, B.A. et al., Cancer Res, 68, 4506 (2008). North America (athymic nude mice)
    149. Chadalapaka, G. et al., Cancer Res, 68(13), 5345 (2008). North America (athymic nude mice)
    150. Cho, S.D. et al., Mol Pharmacol, 77(3), 396 (2010). North America (athymic nude mice)
    151. Jutooru, I. et al., Exp Cell Res, 316(13), 2174 (2010). North America (athymic nude mice)
    152. Zawel, L. et al., PNAS, 99(5), 2848 (2002). North America (athymic nude mice)
    153. Donawho, C.K. et al., Clin Cancer Res, 13(9), 2728 (2007). North America (athymic nude mice)
    154. Rockett, J.C. et al., Br J Cancer, 75(2), 258 (1997). UK (athymic nude mice)
    155. Kan, T. et al., Gastroenterol, 136(5), 1689 (2009) North America (athymic nude mice)
    156. Zhang, S. et al. Mol Cancer Ther, 11, 108 (2012). North America (athymic nude mice)
    157. Zhang, K.-X. et al., Breast Cancer Res Treat, 125, 89 (2011). North America (athymic nude mice)
    158. Zhang, K.-X. et al., Breast Cancer Res Treat, 125, 89 (2011). North America (athymic nude mice)
    159. Liu, Z. et al., Nano Res, 3, 222 (2010). North America (athymic nude mice)
    160. Rimawi, M.R. et al., Clin Cancer Res, 17, 1351 (2011). North America (athymic nude mice)
    161. Zhao, Y. et al., Cancer Res, 71, 4585 (2011). North America (athymic nude mice)
    162. Scaltriti, M. et al., Mol Cancer Ther, 10, 817 (2011). North America (athymic nude mice)
    163. Massey, A.J. et al., Mol Cancer Ther, 9, 906 (2010). Switzerland (athymic nude mice)
    164. Maira, S.-M. et al., Mol Cancer Ther, doi:10.1158/1535-7163.MCT-11-0474. Switzerland (athymic nude mice)
    165. O'Donovan, N. et al., Invest New Drugs, 29, 752 (2011). UK (BALB/c nude mice)
    166. Chao, O. et al., J Med Chem, 52, 7808 (2009). North America (athymic nude mice)
    167. Yu, Y.A. et al., Mol Cancer Ther, 8, 141 (2009). North America (athymic nude mice)
    168. Haddad, D. et al., J Translational Med, 9, 36 (2011). North America (athymic nude mice)
    169. Gourdeau, H. et al., Cancer Chemother Pharmacol, 61, 911 (2008). North America (athymic nude mice)
    170. Liu, T.W. et al., Bioconjugate Chem, 22, 1021 (2011). North America (athymic nude mice, athymic nude rats)
    171. Alzani, R. et al., Exp Hematol, 38, 259 (2010). Italy (SCID mice)
    172. Sehdev, V. et al., Mol Cancer Ther, doi: 10.1158/1535-7163.MCT-11-0623 (2012). North America (athymic nude mice)
    173. Bralten, L.B.C. et al., Ann Neurol, 69, 455 (2011). Netherlands (SCID mice)
    174. Ayuzawa, R. et al., Cancer Letters,280, 31 (2009). North America (SCID mice)
    175. Barok, M. et al., Cancer Letters, 306, 171 (2011). Netherlands (SCID mice)
    176. Zeng, Q. et al., Euro J Cancer, 46, 1132 (2010). North America (athymic nude mice)
    177. Pais, A. et al. Cancer Res, 71(24), 7387 (2011). Israel (SCID mice)
    178. Junttila, T.T. et al., Cancer Cell, 15, 429 (2009). North America (SCID mice)
    179. Daigle, S. R. et al., Cancer Cell, 20, 53 (2011). North America (athymic nude mice)
    180. Patyna, S. et al. Mol Cancer Ther, 5, 1774 (2006). North America (athymic nude mice, NOD.SCID mice)
    181. Zarrinkar, P.P. et al. Blood, 114(14), 2984 (2009). North America (NOD.SCID mice)
    182. Mertz, J.A. et al., PNAS, 108(40), 16669 (2011). North America (athymic nude mice)
    183. Tokalov, S.V. et al., J Biomed and Biotechnol, Article ID 580531, 4 p doi:10.1155/2010/580531 (2010). Germany (athymic nude rats)
    184. Anastas, J.N. et al., Oncogene, doi:10.1038/onc.2011.528 (2011). North America (athymic nude mice)
    185. Mitra, A. et al., Breast Cancer Res, 10:R22 (2008). North America (athymic nude mice)
    186. Volk, L.D. et al., Neoplasia, 10(6), 613 (2008). North America (athymic nude mice)
    187. Hiraga, T. et al., Cancer Res, 61, 4418 (2001). North America (athymic nude mice)
    188. Mukhopadhyay, K.D. et al., PLoS ONE, 6(6), e20473 (2011). North America (athymic nude mice)
    189. Bandyopadhyay, A. et al., PLoS ONE, 5(4), e10365 (2010). North America (athymic nude mice)
    190. Walsh, C. et al., Cancer Biol Ther, 9(10), 778 (2010). North America (athymic nude mice, BALB/c SCID mice)
    191. Lee, S.-M. et al., ACS Nano, 4(9), 4971 (2010). North America (athymic nude mice)
    192. Kerjaschki, D. et al. J Clin Invest, 121(5), 2000 (2011). Germany (SCID mice)
    193. Whitehurst, B. et al., Int J Cancer, 121, 2181 (2007). North America (SCID mice)
    194. Graeser, R. et al., Int J Cancer, 122, 1145 (2008). Germany (SCID mice)
    195. Gomez-Manzano, C. et al., Neuro-Oncol, 10, 940 (2008). North America (athymic nude mice)
    196. et al., Cancer Gene Ther, 12, 947 (2005). Germany (athymic nude mice)
    197. Verheije, M.H. et al., J Virol, 83(15), 7507 (2009). Netherlands (athymic nude mice)
    198. Ke, L.D. et al., Clin Cancer Res, 6, 2562 (2000). North America (athymic nude mice)
    199. Clark, A.J. et al., J Neurosurg, 112, 18 (2010). North America (athymic nude mice)
    200. Calzolari, A. et al., Transl Oncol, 3(2), 123 (2010). Italy (athymic nude mice)
    201. Schiappacassi, M. et al., Mol Cancer Ther, 7(5), 1164 (2008). Italy (athymic nude mice)
    202. Yoon, H. et al., J Cellular Biochem, 108, 832 (2009). North America (athymic nude mice)
    203. Abourbeh, G. et al., Nucl Med and Biol, 34, 55 (2007). Israel (athymic nude mice)
    204. Benny, O. et al., FASEB J, 22, 488 (2008). Israel (CD-1 nude mice)
    205. Yin, S. et al., Neuro-Oncol, 12(1), 19 (2010). Sweden (athymic nude rats)
    206. Khan, Z. et al., Neuro-Oncol, 12(6), 549 Sweden (athymic nude rats)
    207. Buursma, A.R. et al., J Nucl Med, 46, 2068 (2005). Netherlands (athymic nude rats)
    208. Gunasekaran, K. et al., J Biol Chem, 285(25), 19637 (2010). North America (NOD.SCID mice)
    209. Li, J.-L. et al., Cancer Res, 67(23), 11244 (2007). Germany (BALB/c SCID mice)
    210. Holen I., et.al., Breast Cancer Research 2012, 14:R86. United Kingdom (BALB/c nude mice)
    211. Hennessy, B.T. et al. Clin Cancer Res, 13(24), 7421 (2007). North America (athymic nude mice)
    212. Nakamori, M. et al., 9, 2727 (2003). North America (athymic nude mice)
    213. Ma, L. et al., Acta Biochim Biophys Sin, 42(9), 593 (2010). Asia (BALB/c nude mice)
    214. Shao, M. et al., Cancer Res, 69, 9192 (2009). North America (BALB/c nude mice)
    215. Lljin, K. et al., Clin Cancer Res, 15(19), 6070 (2009). Finland (athymic nude mice)
    216. Izhak, L. et al., J Immunol, 183, 732 (2009). Israel (SCID-beige mice)
    217. Inbar-Rozensal, D. et al., Breast Cancer Res, 11, R78 (2009). Israel (CD-1 nude mice)
    218. González, L. et al., J Biol Chem, 281(30), 20851 (2006). Spain (athymic nude mice)
    219. Wu, L. et al., Clin Cancer Res, 11(22), 8195 (2005). North America (athymic nude mice)
    220. Ghosh, A.K. et al., Cancer Res, 56(3), 718 (2005). North America (athymic nude mice)
    221. Tang, L. et al., J Nutr, 135, 287 (2005). North America (athymic nude mice)
    222. Fu, X. et al., Gene Ther, 10, 1458 (2003). North America (athymic nude mice)
    223. Shashkova, E.V. et al., Cancer Res, 68(14), 5896 (2008). North America (athymic nude mice)
    224. Ozawa, T. et al., Mol Pharmaceutics, 1(5), 368 (2004). North America (athymic nude rats)
    225. Bristol, J.A. et al., Mol Ther, 7(6), 755 (2003). North America (athymic nude mice)
    226. Folgiero, V. et al., Cell Death and Disease, 3, e440; doi:10.1038/cddis.2012.179 (2012). Italy (athymic nude mice, SCID mice)
    227. Jensen, M.R. et al., Breast Cancer Res, 10, R33 (2008). Switzerland (athymic nude mice)
    228. Golubovskaya, V.M. et al., J Med Chem, 51(23), 7405 (2008). North America (athymic nude mice)
    229. Hernandez-Alcoceba, R. et al., Human Gene Ther, 11, 2009 (2000). North America (athymic nude mice)
    230. Gutierrez, M.C. et al., JCO, 23(11), 2469 (2005). UK (athymic nude mice)
    231. Mahller, Y.Y. et al. PLoS ONE, 4(1):e4235. doi:10.1371/journal.pone.0004235 (2009). North America (athymic nude mice)
    232. Zhou, Y. et al., J Biol Chem, 286, 32843 (2011). North America (athymic nude mice)
    233. Salvatori, L. et al., PLoS ONE, 7(2), e31467. doi:10.1371/journal.pone.0031467 (2012). Italy (NOD.SCID mice)
    234. Londoño-Joshi, A.I. et al., Breast Cancer Res Treat, DOI 10.1007/s10549-011-1763-0 (2011). North America (NOD.SCID mice)
    235. Joseph, I. et al., Cancer Res, 70, 9494 (2010). North America (athymic nude mice)
    236. Lonardo, E. et al., Cell Stem Cell, 9(5), 433 (2011). Spain (athymic nude mice)
    237. Xiao, K. et al., Biomaterials, 30(30), 6006 (2009). North America (athymic nude mice)
    238. Li, Y. et al., J Immunol, 179, 4263 (2007). North America (SCID mice)
    239. Kumagai, T. et al., J Natl Cancer Inst, 95(12), 896 (2003). North America (beige-nude-xid mice)
    240. Kumagai, T. et al., Clin Cancer Res, 10, 1508 (2004). North America (beige-nude-xid mice)
    241. Audo, I. et al., Invest Ophthalmol Vis Sci, 44, 4192 (2003). North America (athymic nude mice)
    242. Cocco, C. et al., Clin Cancer Res, 16, 4188 (2010). Italy (NOD.SCID mice)
    243. Ayers, G.D. et al., J Ultrasound Med, 29(6), 891 (2010). North America (athymic nude mice)
    244. Ning, S. et al., Cancer Res, 70(19), OF1 (2010). North America (athymic nude rats)
    245. Yee, A.J.M. et al., Breast Cancer Res, 9(4), R47 (2007). North America (CD-1 nude mice, athymic nude rats )
    246. Mercatelli, N. et al., PLoS ONE, 3(12), e4029 (2008). Italy (SCID mice)
    247. Thallinger, C. et al., J Invest Dermatol, 127, 2411 (2007). Germany (SCID mice)
    248. Elsner, L. et al., J Immunol, 179, 5523 (2007). Germany (SCID-beige mice)
    249. Ren, G. et al., J Nucl Med, 50, 1692 (2009). North America (athymic nude mice)
    250. Morello, S. et al., Neoplasia, 13(4), 365 (2011). Italy (athymic nude mice)
    251. Stangl, S. et al., J Immunol, 176, 6270 (2006). Germany (SCID-beige mice)
    252. Phillips, G.D.L. et al., Cancer Res, 68, 9280 (2008). North America (beige-nude-xid mice)
    253. Lee-Hoeflich, S.T. et al., Cancer Res, 68, 5878 (2008). North America (beige-nude-xid mice)
    254. Yao, E. et al., Clin Cancer Res, 15, 4147 (2009). North America (beige-nude-xid mice)
    255. Allegrucci, C. et al., Mol Cancer, 10, 7 (2011). UK (MF1 nude mice)
    256. Brachmann, S.M. et al., PNAS, 106(52), 22299 (2009). North America (athymic nude mice)
    257. Hoeflich, K.P. et al., Clin Cancer Res, 15(14), 4649 (2009). North America (beige-nude-xid mice)
    258. Wong, T.W. et al., Clin Cancer Res, 12(20), 6186 (2006). North America (athymic nude mice)
    259. Halasi, M. et al., Cell Cycle, 9(4), 1214 (2010). North America (athymic nude mice)
    260. Zhang, S. et al., Endocrine-Related Cancer, 16, 835 (2009). North America (athymic nude mice)
    261. Hitosugi, T. et al., Mol Cell, 44(6), 864 (2011). North America (athymic nude mice)
    262. Jimeno, A. et al., Cancer Res, 65, 3003 (2005). North America (athymic nude mice)
    263. Mutsaers, A.J. et al., Clin Cancer Res, 15, 2397 (2009). North America (athymic nude mice)
    264. Guix, M. et al., J Clin Invest, 118(7), 2609 (2008). North America (athymic nude mice)
    265. Donnini, S. et al., Oncogene, doi:10.1038/onc.2011.503 (2011). Italy (athymic nude mice)
    266. Shir, A. et al., Clin Cancer Res, 17, 1033 (2011). Israel (NOD.SCID mice)
    267. Lee, C.M. et al., BMC Cancer, 10, 255 (2010). North America (athymic nude mice)
    268. Alameda, J.P. et al., Cell Death and Disease, 2, e208; doi:10.1038/cddis.2011.82 (2011). Spain (athymic nude mice)
    269. Valle BL, et al,. PLoS ONE 8(4): e61836 (2013). North America (athymic nude mice)
    270. Zhang C.C, et.al., Clinical Cancer Research 1-12; 2012. AACR. France (athymic nude mice)
    271. Carlson B. L, et.al., Curr Protoc Pharmocol. 2011 mar; Chapter 14: Unit 14. 16 (2011). North America (athymic nude mice)
    272. Calles A., et.al., Curr Protoc Pharmacol. 2013 Jun; Chapter 14: Unit 14.26 (2013). North America (NOD.SCID mice, athymic nude mice)
    273. Litzenburger BC., et.al., Clin Cancer Res April 15, 2011. 17; 2314. North America (NOD.SCID mice)
    274. Schott AF, et.al., Clin Cancer Res clincanres.3326.2012; Published Online First January 22, 2013. North America (SCID-beige mice)
    275. Leake K, et.al., PLoS ONE 7(4): e34582 (2012). North America (athymic nude mice)
    276. Zhao S, et.al., Oncogenesis (2013) 2, e76. North America (athymic nude mice)
    277. Hernandez JL, et.al., PLoS ONE 8(9): e72480 (2013). Spain (athymic nude mice)
    278. Jager W, el.al., PLoS ONE 8(3): e59536 (2013). North America (athymic nude mice)
    279. Shin D.H, et.al., JNCI J Natl Cancer Inst (2013). North America (athymic nude mice)
    280. Venkatasubbarao K, et.al., Molecular Cancer 2013, 12:104. North America (athymic nude mice)
    281. Rybczynska A.A, el.al., J Nucl Med September 1, 2013. The Netherlands (athymic nude mice)
    282. Gholami S, et.al., Breast Cancer Research 2013, 15:R26. North America (athymic nude mice)
    283. Zins K, et.al., Mol. Sci. 2013, 14, 17958-17971. Germany (athymic nude mice)
    284. Benavente S, et.al., Clin Cancer Res March 1, 2009 15; 1585. North America (athymic nude mice)
    285. Verhoeff JJC, et.al., Radiation Oncology 2007, 2:38. The Netherlands (athymic nude mice)
    286. Alessandro GD, et.al., Cell Death and Disease (2013) 4, e773. Italy (C.B-17 SCID mice)
    287. Jiang J., et.al., Oncol Rep. 2012 October; 28(4): 1139-1145. North America (athymic nude mice)
    288. Koht HE., et.al., The Journal of Clinical investigation. Volume 122, number 3, March 2012. North America (athymic nude mice)
    289. Barok M., et.al., Breast Cancer Research 2011, 13:R46. The Netherlands (C.B-17 SCID mice)
    290. Thorner Ar., et.al., PLoS ONE 5(10)e13073. North America (athymic nude mice)
    291. Hamada K., et.al., Gynecologic Oncology 99 (2005) S159-S165. North America (athymic nude rats)
    292. Lheureux S., et.al. Transl Oncol. 2013 October; 6(5): 586-595. North America (athymic nude rats)
    293. Millar HJ., et.al., Cancer Epidemiol Biomarkers Prev August 2008 17; 2180. North America (athymic nude rats)
    294. Ayers GD., et.al., JUM June 1, 2010 vol. 29 no. 6 891-90. North America (athymic nude mice)
    295. Cyran CC., et.al., PLoS ONE 8(9): e76009. North America (athymic nude rats)
    296. Daigle SR., et.al., Blood 2013 122: 1017-1025. North America (athymic nude rats)
    297. Jafri SH., et al., Journal of Experimental & Clinical Cancer Research 2010 29:87. North America (C.B-17 SCID mice)
    298. Dingli D., et al., Blood 2003 102: 489-496. North America (C.B-17 SCID mice)
    299. Green TP., et.al., Molecular Oncology 3 (2009), 248-261. France (athymic nude mice)
    300. Kreider JW., at al., Cancer Research 39, 273-276, January 1979. North America (athymic nude mice)
    301. Welsch CW, et.al, JNCI J Natl Cancer Inst (1987) 78 (3): 557-565. North America (athymic nude mice)
    302. Park SI., et.al., Curr Protoc Pharmacol. 2010 December 1; 51: 14.15-14.15.27. North America (athymic nude mice)
    303. Fernandes MS., et.al., Clin Cancer Res August 1, 2009 15; 4847. North America (C.B-17 SCID mice)
    304. Mundra JJ., et.al, JPET August 2012 vol. 342 no. 2 273-287. North America (SCID mice)
    305. Peng KW., et.al., Blood, 1 October 2001. Vol. 98. Numb. 7. North America (C.B-17 SCID mice)
    306. Bhatia N., et.al., J Invest Dermatol. 2013 March ; 133(3): 759-767. North America (athymic nude mice)
    307. Mischek D., et.al., Journal of Biomedicine and Biotechnology, Volume 2009 (2009), Article ID 437284. Germany (SCID-beige mice)
    308. Harrell JC., et.al., Cancer Res September 15, 2006 66; 9308. North America (athymic nude mice)
    309. Kumar S., et.al., Am J Pathol. 2003 December; 163(6): 2531-2541. North America (athymic nude mice)
    310. Schafer JM., et.al., Clin Cancer Res November 2000 6; 4373. North America (athymic nude mice)
    311. Gottardis MM., et.al., J Steroid Biochem. 1988;30(1-6):311-4. North America (athymic nude mice)
    312. O’Regan RM., et. al., JNCI J Natl Cancer Inst (2002) 94 (4): 274-283. North America (athymic nude mice)
    313. Morrison MM., J Clin Invest. 2013;123(10):4329-4343. North America (athymic nude mice)
    314. Suhong Xiao, et.al., The Journal of Biological Chemistry, 287, 12559-12577. North America (athymic nude mice, beige-nude-xid mice, SHrN® mice)
    315. Nguyen N, et.al., Cancer Prev Res. February 2011 4; 248. North America (athymic nude mice)
    316. Wang S, at.al., Cancer Gene Therapy (2002) 9, 1-8. doi:10.1038/sj.cgt.7700402. North America (athymic nude mice)
    317. Mathieu V.et.al, Oncotarget. Apr 2012; 3(4): 399-413. Germany (BALB/c SCID mice)
    318. Vaha-Koskela MJV., et.al., Cancer Res July 15, 2006 66; 7185. The Netherlands (SCID mice)
    319. Thallinger C., et.al., Journal of Investigative Dermatology (2003) 120, 1081-1086; doi:10.1046/j.1523-1747.2003.12252.x. Germany (C.B-17 SCID mice)
    320. Mathieu MG., et.al., Cell Death and Disease (2014) 5, e1061; doi:10.1038/cddis.2014.29 Published online 13 February 2014. United Kingdom (NOD.SCID mice)
    321. Hafner C., et.al., Int. J. Cancer: 114, 426-432 (2005). Germany (C.B-17 SCID mice)
    322. Luciani F, et.al., Oxford Journals Medicine JNCI J Natl Cancer Inst Volume 96, Issue 22 Pp. 1702-1713. Italy (C.B-17 SCID mice)
    323. Ong C.C., et.al., JNCI J Natl Cancer Inst (2013) djt054 doi: 10.1093/jnci/djt054. North America (beige-nude-xid mice)
    324. Lotan T., et.al., Cancer Res. Apr 1, 2008; 68(7): 2166-2175. North America (beige-nude-xid mice)
    325. Goel A., et.al., Blood 2007 110: 2342-2350. North America (beige-nude-xid mice)
    326. Zeng Y, et.al., J Biol Chem. Apr 22, 2011; 286(16): 13985-13994. North America (C.B-17 SCID mice)
    327. Hofmann M., et.al., Neoplasia (New York, N.Y.) (Impact Factor: 5.48). 09/2009; 11(8):812-22. Germany (NOD.SCID mice)
    328. Wang L., et.al., J Clin Neurosci. Jun 2012; 19 (6): 881-883. North America (NOD.SCID mice)
    329. Sharad S. Singhal, et.al., Cancer Res. May 15, 2009; 69(10): 4244-4251. North America (athymic nude mice)
    330. Amornphimoltham P., et.al., Clin Cancer Res. Mar 15, 2013; 19(6): 1375-1388. North America (athymic nude mice)
    331. Ricci-Vitiani L., et.al., Cell Death and Differentiation (2008) 15, 1491-1498; doi:10.1038/cdd.2008.72; published online 23 May 2008. Italy (athymic nude mice)
    332. Chiron M., et.al., Mol Cancer Ther June 2014 13; 1636. France (NMRI nude mice)
    333. Presnell SC., et.al., Am J Pathol. Sep 2001; 159(3): 855-860. North America (athymic nude mice)
    334. Stebbing J., et.al., Cancer. Volume 120, Issue 13, pages 2006-2015, 1 July 2014. North America (athymic nude mice)
    335. Weekes CD., et.al., Neoplasia. Aug 2012; 14(8): 69-701. North America (athymic nude mice)
    336. Pitts TM, et al., (2014) PLoS ONE 9(11): e113037. doi:10.1371/journal.pone.0113037. North America (athymic nude mice)
    337. Toussaint G.L., et.al., Molecular Cancer 2012, 11:32. North America (athymic nude mice)
    338. Bradshaw-Pierce E.L., et.al., Front. Pharmacol., 22 March 2013 | doi: 10.3389/fphar.2013.00022. North America (athymic nude mice)
    339. Petit V., et.al., Laboratory Investigation (2013) 93, 611-621; doi:10.1038/labinvest.2013.44; published online 4 March 2013. France (BALB/c nude mice)
    340. Anne L van de Ven, et.al., New Journal of Physics 15 (2013) 055004. North America (SCID-beige mice)
    341. Tchoghandjian A., et.al., Cell Death & Differentiation 21, 735-747 (May 2014). France (athymic nude mice)
    342. Veeravagu A., et.al., Clin Cancer Res November 15, 2008 14; 7330. North America (athymic nude mice)
    343. Mei J., et.al., Mol Cell Biol. Sep 2011; 31(7):3584-3592. North America (NOD.SCID mice)
    344. Wang J., et al., Cancer Cell 12, 239-251, September 2007. North America (athymic nude mice)
    345. Chisholm EJ., et.al., Cancer Res March 15, 2009 69; 2655. United Kingdom (BALB/c nude mice)
    346. Gao Z., et.al., International Journal of Cancer Volume 82, Issue 3, pages 346-352, 30 July 1999. North America (athymic nude mice)
    347. Dauchy RT., et.al., Comparative Medicine. Vol. 62, No 2, April 2012, pages 99 - 108. North America (athymic nude rats)
    348. Diagle SR., et.al., Blood: 122 (6). August 8, 2013. North America (athymic nude rats)
    349. Serra V, et.al., J Clin Invest. 2013;123(6):2551-2563. Spain (athymic nude mice, NMRI nude mice)
    350. Nephew KP., et. al., Cancer Res Published OnlineFirst July 17, 2014. North America (athymic nude mice)
    351. Pirazzoli V., et.al., Cell Reports 7, 999-1008, May 22, 2014. North America (athymic nude mice)
    352. Garcia R.R., et.al., Am J Clin Exp Urol 2014;2(1):82-91. North America (athymic nude mice)
    353. Nofiele JT., et.al., PLoS ONE 9(5): e97950. North America (athymic nude rats)
    354. Kolev, V.N., et al., Cancer Res January 15, 2015 75; 446. North America (SHrN™ mice, NOD.SCID mice)
    355. Colletti, JA II et al. G3 (Bethesda). 4 (2014) 1385-1394. North America (Brown Norway rats)
    356. Munson, JM., et al. Cancer Res. 73 (2013) 1536-1546. Swtizerland (Fisher 344 rats)
    357. Bhattacharya, A., et al. Carcinogenesis. 34 (2013) 2593-2599. North America (Fisher 344 rats)
    358. Janakiram, NB., et al., Cancer.Prev.Res.(Phila). 6 (2013) 1251-1261. North America (Fisher 344 rats)
    359. Ravillah, D., et al. et al., J.Pharmacol.Exp.Ther. 348 (2014) 59-68. North America (Fischer 344 rats)
    360. Shi, N., et al. Oncotarget. 5 (2014) 11333-11344. North America (Fischer 344 rats)
    361. Yang, L., et al., Int.J.Biochem.Mol.Biol. 3 (2012) 46-57. China (Fischer 344 rats)
    362. Stypula-Cyrus, Y., et al., FEBS Lett. 588 (2014) 829-835. North America (Fischer 344 rats)
    363. Khazal, KF., et al. Anticancer Res. 33 (2013) 1519-1523. North America (Spraque Dawley rats)
    364. Ouyang, N., et al. Int.J.Oncol. 42 (2013) 643-650. North America (Fischer 344 rats)
    365. Ostertang D., et.al., Neuro Oncol. 2012 February; 14(2): 145–159. North America (B6C3F1 mice)
    366. Rashid OM., et.al., Journal of Thoracic Disease. Vol 5, No 4 (August 2013). North America (BALB/c mice)
    367. Anz, D., et al, Int.J.Cancer 129 (2011) 2417-2426. Germany (C57BL/6 mice; BALB/c mice)
    368. Barbieri, A., et al, J.Cell.Mol.Med. 16 (2012) 920-926. Italy (C57BL/6 mice)
    369. Adinolfi, E., et al. Cancer Res. 72 (2012) 2957-2969. Italy (C57BL/6 mice; BALB/c mice)
    370. Gurzov, EN., et al. Oncogene 27 (2008) 641-652. Spain (C57BL/6 mice)
    371. Basile, LA., et al. J.Transl.Med. 6 (2008) 26-5876-6-26. North America (C57BL/6 mice)
    372. Balkow, S., et al, Exp.Dermatol. 18 (2009) 78-87. Germany (C57BL/6 mice)
    373. Llopiz, D., et al, Int.J.Cancer 125 (2009) 2614-2623. Spain (C57BL/6 mice)
    374. Jacobs, C., et al, Int.J.Cancer 128 (2011) 897-907. Germany (C57BL/6 mice)
    375. Aranda, F., et al, Cancer Res. 71 (2011) 3214-3224. 2011. Spain (C57BL/6 mice)
    376. Li, X., et al, Oncogene 27 (2008) 7118-7130. North America (C57BL/6 mice)
    377. Spitzer, D., et al, Cancer Res. 72 (2012) 201-209. North American (C57BL/6 mice)
    378. Uluckan, MC., et al, J.Cell.Biochem. 104 (2008) 1311-1323. North American (C57BL/6 mice)
    379. Bandyopadhyay, A., et al. PLoS One 5 (2010) e10365. North America (BALB/c mice)
    380. Cambien, B., et al, PLoS One 6 (2011) e28842. France (BALB/c mice)
    381. Cooney, CA., et al, Breast Cancer Res. 13 (2011) R58. North America (BALB/c mice)
    382. Israyelyan, A., et al. Virol.J. 5 (2008) 68-422X-5-68. North America (BALB/c mice)
    383. Jungwirth, U., et al. et al, Mol.Pharmacol. 81 (2012) 719-728. Austria (BALB/c mice)
    384. Lapteva, N., et al. J.Immunother. 32 (2009) 145-156. North America (BALB/c mice, C57BL/6J mice)
    385. Mojic, M., et al. Mol.Pharmacol. 82 (2012) 700-710. Serbia (BALB/c mice)
    386. Qiao, Y., et al. Oncotarget 2 (2011) 59-68. North America (BALB/c mice)
    387. Vanrell, L., et al, Mol.Ther. 19 (2011) 1245-1253. Spain (BALB/c mice)
    388. Vigneswaran, N. et al. Exp.Mol.Pathol. 90 (2011) 215-225. North America (BALB/c mice)
    389. Walsh, C., et al, Cancer.Biol.Ther. 9 (2010) 778-790. North America (BALB/c mice)
    390. Zhang, M., et al, Cancer Res. 68 (2008) 4674-4682. North America (BALB/c mice)
    391. Zigmond, E., et al. PLoS One 6 (2011) e28858. Israel (BALB/c mice)
    392. Ganesh, S., et al. Mol Cancer Ther (2016) Jul 7. North America (athymic nude mice)
    393. Jiménez-Valerio, G. et al. Cell Rep. (2016) May 10; 15(6):1134-43. Spain (athymic nude mice)
    394. Zhao, S., et al., Clin Cancer Res. (2016) Jun 7. North America (athymic nude mice)
    395. Francis, DM., et al. Clin Cancer Res. (2016) Feb 1; 22(3):633-43. North America (athymic nude mice)
    396. Crottès D., et al. Cancer Res. 2016 Feb 1; 76(3):607-18. France (SHrN™ mice)
    397. Kathagen-Buhmann A., et al. Neuro Oncol. 2016 Feb 24. Germany (SHrN™ mice)
    398. Jones R.J., et al. Clin Cancer Res. 2016 Jun 13. North America (C.B-17 SCID mice)
    399. Alagpulinsa D.A., et al. Mol Cancer Ther. 2016 Feb; 15(2):241-50. North America (C.B-17 SCID mice)
    400. Halle B., et al. J Neurooncol. 2016 Jan; 126(1):47-55. Denmark (athymic nude rats)
    401. Debeb B.G., et al. J Natl Cancer Inst. 2016 Apr 13; 108(8). North America (SCID-beige mice)
    402. Hudson K., et al. Mol Cancer Ther. 2016 May; 15(5):877-89. United Kingdom (SCID-beige mice)
    403. Gravekamp, C., et al. (2004). Experimental Biology and Medicine, 229(7), 665-675. North America (BALB/c mice)
    404. Toussaint, M., et al. Theranostics, 2017; 7(2): 436-451. France (athymic nude rat)
    405. Li, R., et. al, Current Cancer Drug Targets, 2014, 14, 274-285. China (athymic nude mouse)
    406. Schoenfeld, J.D., et al. Redox Biol. 2018 Apr;14:417-422. North America (athymic nude mouse)
    407. Sciegienka S.J., et al. Free Radic Biol Med. 2017 Jul;108:354-361. North America (athymic nude mouse)
    408. Segatto, I., et al. Aging, 8(5), 958-976. United Kingdom (athymic nude mouse)
    409. Sen, T., et al. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 2017 23(20), 6239-6253. North America (athymic nude mouse)
    410. Shao, C., et al. J Biol Chem. 2015 Jan 23;290(4):2024-33. North America (athymic nude mouse)
    411. Stafman, L.L., et al. Oncotarget. 2018 Apr 27; 9(32): 22665–22679. North America (athymic nude mouse)
    412. Tan Q., et al. Br J Cancer. 2015 Mar 3; 112(5): 832–840. North America (athymic nude mouse)
    413. Toden S., et al. Oncotarget. 2016 Mar 29; 7(13): 16158–16171. North America (athymic nude mouse)
    414. Wang W., et al. J Neurosurg. 2018 Mar;128(3):695-700. North America (athymic nude mouse)
    415. Waters A.M., et al. Mol Cancer Ther. 2016 May; 15(5): 911–921. North America (athymic nude mouse)
    416. Yan H., et al. Oncotarget. 2016 Jul 12; 7(28): 43352–43362. North America (athymic nude mouse)
    417. Yan S.B., et al. Invest New Drugs. 2018; 36(4): 536–544. North America (athymic nude mouse)
    418. Yeo S.K., et al. Cancer Res. 2016 Jun 1; 76(11): 3397–3410. North America (athymic nude mouse)
    419. Zumwalt T.J., et al. Cancer Prev Res (Phila). 2017 Mar; 10(3): 208–218. North America (athymic nude mouse)
    420. Alexander M.S., et al. Cancer Res. 2018 Sep 25. pii: canres.1680.2018. North America (athymic nude mouse)
    421. Choi A.H., et al. Surgery. 2018 Feb;163(2):336-342. North America (athymic nude mouse)
    422. Donabedian P.L., et al. EJNMMI Res. 2018; 8: 59. North America (athymic nude mouse)
    423. Nguyen O.N., et al. Cancer Res. 2017 Mar 15;77(6):1427-1438. Europe (BALB/c mice)
    424. Barrett, J. A., et al. 2018. Cancer Gene Therapy, 25(5-6), 106-116. North American (C57BL/6 mice)
    425. Thisgaard, H., et al. 2016. Theranostics, 6(12), 2278-2291. Denmark (athymic nude rats)
    426. Buck, J. R., et al. 2015. PloS One, 10(10), e0141659. North America (athymic nude rats)
    427. Gruslova, A., 2015. Journal of Neuro-Oncology, 124(3), 365-372. North America (athymic nude rats)
    428. Qureshi-Baig, K., 2016. PloS One, 11(1), e0146052. Europe (NOD.SCID mice)
    429. Torres-Guzman, R., et al. 2017. Oncotarget, 8(41), 69493-69507. North America (NOD.SCID mice)
    430. Zhang, Y., et al. 2018. Nature Communications, 9(1), 4080-018-06177-2. North America (NOD.SCID mice)
    431. Banerjee, K., et al. 2018. Clinical Oncology and Research, 1(1). North America (NOD.SCID mice)
    432. Frosina, G., et al. 2018. Scientific Reports, 8(1), 14191-018-32578-w. Europe (NOD.SCID mice)
    433. Gross, A. C., et al. 2018. JCI Insight, 3(16), 10.1172/jci.insight.99791. North America (C.B-17 SCID mice)
    434. Kryeziu, K., et al. 2016. Oncotarget, 7(19), 27379-27393. Europe (C.B-17 SCID mice)
    435. Ryan, M. C., et al. 2017. Blood, 130(18), 2018-2026. North America (C.B-17 SCID mice)
    436. Abrams, T., et al. 2018. Clinical Cancer Research, 24(17), 4297-4308. North America (SCID-beige mice)
    437. Butler, K. A., et al. 2017. Neoplasia (New York, N.Y.), 19(8), 628-636. North America (SCID-beige mice)
    438. Gill, S. E., et al. 2017. Oncotarget, 8(49), 85214-85223. North America (SCID-beige mice)
    439. Goncalves, A. F., et al. 2017. Nature Communications, 8(1), 1466-017-01514-3. Europe (SCID-beige mice)
    440. Park, J. H., et al. 2016. Cell Reports, 14(9), 2154-2165. North America (SCID-beige mice)
    441. Debeb, B. G., et al. 2016. Journal of the National Cancer Institute, 108(8). North America (SCID-beige mice)
    442. Song, W., et al. 2017. Oncogene, 36(40), 5620-5630. North America (NOD.SCID mice)
    443. Williams, A. P., et al. 2018. Translational Oncology, 12(1), 84-95. North America (athymic nude mouse)
    444. Yu, X., et al. 2018. International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 47(3), 957-971. Asia (athymic nude mouse)
    445. Ziegler, J., et al. (2017). Oncotarget, 8(42), 71833-71844. North America (athymic nude mouse)
    446. Van de Sande, L., et al. (2019). BMC Cancer, 19(1), 424. Belgium (athymic nude rats)
    447. Grünewald, S., et al. (2019). Int J Cancer, 145(5), 1346-1357. Germany (athymic nude rats)
    448. Owonikoko, T.K., et al. (2019). PLoS One, 14(2), e0206309. North America (athymic nude rats)
    449. Atkins, A., et al. (2019). Ann Biomed Eng, 47(4), 980-989. Canada (athymic nude rats)
    450. Vermandel, M., et al. (2019). Photodiagnosis Photodyn Ther, 25, 166-176. France (athymic nude rats)
    451. Vega, F.M., et al. (2019). EBioMedicine, 49, 82-95.Spain (CB-17 mice)
    452. Wang, Y., et al. (2019). Mol Cancer Ther, 19(2), 364-374. North America (CB-17 mice)
    453. Nguyen, T., et al. (2019). Cell Rep, 27(2), 491-501.e6 North America (CB-17 mice)
    454. Pfitzer, L., et al. (2019). Cell Death Dis, 10(4), 302. Germany (CB-17 mice)
    455. Fonti, C., et al. (2019). Int J Cancer, 145(5), 1299-1311. France (SCID-beige mice)
    456. Felder, M., et al. (2019). Gynecol Oncol, 152(3), 618-628 North America (SCID-beige mice)
    457. Torres, D., et al. (2019). PLoS One, 4(11), e0224564. North America (SCID-beige)
    458. Santiago-O'Farrill, J.M., et al. (2020). Bast RC Jr. Cancer, 126(4), 894-907. North America (SCID-beige)
    459. McDaid, W.J., et al. (2019). Nanoscale, 11(42), 20261-20273. UK (SCID-beige)
    460. Kanakkanthara, A., et al. (2019). Nat Commun, 10(1), 4632. North America (SCID-beige)
    461. Le Joncour, V., et al. (2019). Mol Cancer Ther, 18(10), 1721-1730. Finland (SCID-beige)
    462. Guerra-Rebollo, M., et al. (2019). Sci Rep, 9(1), 9549. Spain (SCID-beige)
    463. Owonikoko, T.K., et al. (2019). PLoS One, 14(2), e0206309. North America (SCID-beige)
    464. Wang, W., et al. (2019). J Clin Invest, 129(3), 1015-1029. North America (SCID-beige)
    465. Assimon, V.A., et al. (2019). ACS Chem Biol, 14(2), 236-244. North America (SCID-beige)
    466. Nachliely, M., et al. (2019). J Steroid Biochem Mol Biol, 188, 8-16. Israel (SCID-beige)
    467. Harris, F.R., et al. (2019). Mol Oncol, 13(2), 132-152. North America (SCID-beige)
    468. Adler-Levy, Y., et al. (2019). Sensors (Basel), 19(9). Israel (SCID-beige)
    469. Ramirez, A.B. et al. (2019). BMC Cancer, 19(1), 220. North America (SCID-beige)
    470. Schweppe, R.E., et al. (2019). Mol Cancer Res, 17(5), 1036-1048. North America (SCID-beige)
    471. Shamai ,Y., et al. (2019). Stem Cells, 37(2), 176-189. Israel (SCID-beige)
    472. Vandergaast, R., et al. (2019). Cancer Gene Ther, 27(3-4), 179-188. North America (SCID-beige)
    473. Kim, I.S., et al. (2019). Nat Cell Biol, 21(9), 1113-1126. North America (SCID-beige)
    474. Cai, D., et al. (2019). Nat Commun, 10(1), 4621. North America (CB-17)
    475. Ceresa, D., et al. (2019). Int J Mol Sci, 20(16). Italy (NOD.SCID)
    476. Aasen, S.N., et al. (2019). Mol Cancer Ther, 8(11), 2171-2181. Norway (NOD.SCID)
    477. Arroyo-Crespo, J.J., et al. (2019). Int J Cancer, 145(8), 2267-2281. Spain (NOD.SCID)
    478. Gatta, L.B., et al. (2019). Cancers (Basel), 11(9), pii: E1219. Italy (NOD.SCID)
    479. Ghosh, S.,et al., Front Oncol, 9, 17. Israel (NOD.SCID)
    480. Kalli, M., et al. (2019). Front Oncol, 9,32. Cyprus (NOD.SCID)
    481. Ron, A., et al. (2019). Cancer Res, 79(18), 4767-4775. Germany (NOD.SCID)
    482. Santoro, A., et al. (2019). Cell Rep, 26(3), 624-638.e8. Italy (NOD.SCID)
    483. Schrama, D., et al. (2019). Int J Cancer, 145(4), 1020-1032. Germany (NOD.SCID)
    484. Stafman, L.L., et al. Sci Rep, 9(1), 13259. North America (NOD.SCID)
    485. Terrasi, A., et al. (2019). EBioMedicine, 41, 214-224. Italy (NOD.SCID)
    486. Woosley, A.N., et al.Oncogene, 38(20), 3794-3811 North America (NOD.SCID)
    487. Wu, J. et al. (2019). Nature, 572(7769), 402-406. North America (NOD.SCID)
    488. Aasen, S.N., et al. (2019). Int J Mol Sci, 20(17). Norway (NOD.SCID)
    489. Amodio, N., et al., (2019). Cancers (Basel), 18, 11(2). pii: E236. Italy (NOD.SCID)
    490. Badarni, M., et al. (2019). JCI Insight, 5. pii: 125341. Israel (NOD.SCID)
    491. Benguigui M, et al. (2019). Sci Rep, 9(1), 12613. Israel (NOD.SCID)
    492. Falah, M., et al. (2019). Int J Mol Sci, 20(19). Israel (NOD.SCID)
    493. Feng, Y., etal. (2019). J Exp Clin Cancer Res, 38(1), 54. China (NOD.SCID)
    494. Hammer, S., et al. (2020) Clin Cancer Res, 26(8),1985-1996. Germany (NOD.SCID)
    495. Hoogi, S., et al. (2019). J Immunother Cancer, 7(1), 243. Israel (NOD.SCID)
    496. Krishnamoorthy, G.P., et al. (2019). Cancer Discov, 9(2), 264-281. North America (NOD.SCID)
    497. La Rocca, F., et al. (2017). Cell Oncol (Dordr), 40(5), 483-496. Italy (NOD.SCID)
    498. Otto, M., et al. (2019). Clin Oral Investig, 23(10), 3767-3775. Germany (NOD.SCID)
    499. Punzi, S., et al. (2019). Breast Cancer Res, 21(1), 123. Italy (NOD.SCID)
    500. Sharma, S. et al., (2019). EBioMedicine, 44, 194-208. North America (NOD.SCID)
    501. Fusciello, M., etal. (2019). Nat Commun, 10(1), 5747. Canada (athymic nude mice)
    502. Neiveyans, M., et al. (2019). Mabs, 11(3), 593-605. France (athymic nude mice)
    503. Ryu, J.S., et al. (2019). Cancers (Basel), 11(4), pii: E574. Korea (athymic nude mice)
    504. Sayyad M.R., et al. (2019). Breast Cancer Res Treat, 178(1), 35-49. North America (athymic nude mice)
    505. Schweppe, R.E., et al. (2019). Mol Cancer Res, 17(5), 1036-1048. North America (athymic nude mice)
    506. Stafman, L.L., et al. (2019). Transl Oncol, 12(2), 200-208. North America (athymic nude mice)
    507. Akla B., et al. (2020). Mol Cancer Ther, 19(1), 168-177. France (athymic nude mice)
    508. Assimon, V.A., et al. (2019). ACS Chem Biol, 14(2), 236-244. North America (athymic nude mice)
    509. Belli, V., et al. (2019). Exp Clin Cancer Res, 38(1), 236. Italy (athymic nude mice)
    510. Capasso, A., et al. (2019). Mol Cancer Ther,18(11), 1916-1925. North America (athymic nude mice)
    511. Casagrande N., et al. (2019). Haematologica, 104(3), 564-575. Italy (athymic nude mice)
    512. Duo, L., et al. (2019). Nat Commun, 10(1), 5051. China (athymic nude mice)
    513. Eskra, J.N., et al. (2019). Prostate, 79(2), 223-233.North America (athymic nude mice)
    514. Fok, J.H.L., et al. (2019). Nat Commun, 10(1), 5065. UK (athymic nude mice)
    515. Formisano, L., et al. (2019). Nat Commun, 10(1), 1373. North America (athymic nude mice)
    516. Hain, B.A., et al. (2019). JCSM Rapid Commun, 2(1), pii: e00075. North America (athymic nude mice)
    517. Hegde, G.V., et al. (2019). Elife, 8, pii: e46551. North America (athymic nude mice)
    518. Kietzman, W.B., et al. (2019). Mol Cancer Ther, 18(12), 2220-2232. North America (athymic nude mice)
    519. Liu, P., et al. (2019). Nat Commun, 10(1), 1486. France (athymic nude mice)
    520. Maaland, A.F., et al. (2019). Eur J Nucl Med Mol Imaging, 46(11), 2311-2321. Norway (athymic nude mice)
    521. Moon, H.H. et al. (2019). Endocrinology, 160(8), 1786-1796. North America (athymic nude mice)
    522. Nguyen, T., et al. (2019). Cell Rep, 27(2), 491-501.e6. North America (athymic nude mice)
    523. Rello-Varona, S., et al. (2019). Sci Rep, 9(1), 3816. Spain (athymic nude mice)
    524. Williams, A.P., et al. (2019). Transl Oncol, 12(10), 1364-1374. North America (athymic nude mice)
    525. Wu, J., et al. (2019). Nature, 572(7769), 402-406. North America (athymic nude mice)
    526. Yang, H., et al. (2019). Clin Cancer Res, 25(18), 5702-5716. North America (athymic nude mice)
    527. Yang, L., et al. (2019). Sci Transl Med, 11(476). North America (athymic nude mice)
    528. Chang, Y.C., et al. (2017). Sci Rep, 7(1), 9746. North America (RAG2 KO(SD))
    529. Fisher, C., et al. (2019). J Clin Med, 8(12), pii: E2214. North American (RAG2 KO(SD))
    530. Chen, Z.H., et al. (2019). J Exp Clin Cancer Res, 14;38(1), 196. China (B-NDG)
    531. Chen, Z., et al. (2019). EBioMedicine, 47, 208-220. China (B-NDG)
    532. Dai, K, et al. (2018). Eur J Immunol, 48(4), 683-695. China (B-NDG)
    533. Li, Y., et al. (2018). J Exp Clin Cancer Res, 37(1), 276. China (B-NDG)
    534. Sun, B., et al. (2019). Cancer Immunol Res, 7(11), 1813-1823. China (B-NDG)
    535. Wang, J., et al. (2020). Thorac Cancer. China (B-NDG)
    536. Wang, Q., et al. (2018). Clin Cancer Res, 24(4), 950-962. China (B-NDG)
    537. Xia, J., et al. (2020). Mol Oncol, 14(4), 763-778. China (B-NDG)
    538. Xiao, X., et al. (2017). Cell Death Dis, 8(9), e3050. China (B-NDG)
    539. Ao, X., et al. (2019). J Immunother, 42(8), 284-296. China (B-NDG)
    540. Chen, H.D., et al. (2020). Int J Biol Sci, 16(7), 1207-1217. China (B-NDG)
    541. Gao , X., et al. (2019). Clin Cancer Res, 25(4), 1291-1301. China (B-NDG)
    542. Gong, J., et al. (2020). Artif Cells Nanomed Biotechnol, 48(1), 408-414. China (B-NDG)
    543. Chen, R., et al. (2020). Cancer Lett. 469, 162-172. China (B-NDG)
    544. Huang W., et al. (2020). Cell Death Differ, 27(5), 1709-1727. China (B-NDG)
    545. Lei, H., et al. (2019). Cancer Invest, 37(6), 242-252. China (B-NDG)
    546. Sun, Y., et al. (2019). EBioMedicine, 43, 171-179. China (B-NDG)
    547. Wang, D., et al. (2018). J Cell Mol Med, 22(12), 6202-6212. China (B-NDG)
    548. Wu, R., et al. (2019). Pharmacol Res, 150, 104454. China (B-NDG)
    549. Xiao, H., et al. (2019). Cancer Cell Int, 19, 218. China (B-NDG)
    550. Yang, D. , et al. (2019). J Immunother Cancer, 7(1), 171. China (B-NDG)
    551. Zhan, Y., et al. (2020). Mol Cancer, 19(1), 25. China (B-NDG)
    552. Zhang, P., et al. (2020). J Biomed Sci, 27(1), 30. China (B-NDG)
    553. Zhao, B., et al. (2019). Theranostics, 9(7), 1837-1850. China (B-NDG)
    554. Wei, .T et al. (2020).mBio, 11(3):e00908-20. North America (athymic nude mice)
    555. Tuominen, S., et al. (2020). Eur. J. Nucl. Med. Mol. Imaging, doi: 10.1007/s00259-020-05115-z. Finland (athymic nude mice)
    556. Elwaie, TA., et al. (2020). J Med Chem. 2020 Dec 24;63(24):15906-15945. doi: 10.1021/acs.jmedchem.0c01647. North America (athymic nude mice)
    557. Gómez-Aleza, C., et al. (2020). Nat Commun. 11(1):6335. Spain (athymic nude mice)
    558. Parsels, LA., et al. (2020). Mol Cancer Ther. doi: 10.1158/1535-7163.MCT-20-0365. North America (athymic nude mice)
    559. Gergen, AK., et al. (2020). J Surg Res, S0022-4804(20)30754-X. North America (athymic nude mice)
    560. Gadkari, K., et al. (2020). Nutrients, 12(12):3631. North America (athymic nude mice)
    561. Wu, Q., et al. (2020). Cell Death Dis, 11(11):1015. China (athymic nude mice)
    562. Yi, J., et al. (2020). Proc Natl Acad Sci U S A, 117(49):31189-31197. North America (athymic nude mice)
    563. Capone, E., (2020). Cancers (Basel), 12(10):2989. Italy (athymic nude mice)
    564. Kim, SI., et al. (2020). Int J Mol Sci, 21(19):7326. North America (athymic nude mice)
    565. Bownes, LV., et al. (2021). Transl Oncol,14(1):100893. North America (athymic nude mice)
    566. Ridwan, SM., et al. (2020). Nanomedicine (Lond), 15(24):2369-2383. North America (athymic nude mice)
    567. Scribner, JA., et al. (2020). Mol Cancer Ther, doi: 10.1158/1535-7163. North America (athymic nude mice)
    568. Santich, BH., et al. (2021). Clin Cancer Res, 27(2):532-541. North America (athymic nude mice)
    569. Roger, E., et al. (2020) Cells, 9(9):2110. Germany (athymic nude mice)
    570. Sun, Y., et al. (2020). Cancer Res, 80(21):4840-4853. North America (athymic nude mice)
    571. Dabaghi, M., et al. (2020). Cancers (Basel), 12(9):2562. Germany (athymic nude mice)
    572. Ramachandran, S., and Srivasta, S. (2020). Mol Ther Oncolytics, 19:19-32. North America (athymic nude mice)
    573. Shibata, M., et al. (2020). Mol Cancer Ther, 19(10):2175-2185. North America (athymic nude mice)
    574. Guffanti, F., et al. (2020). Cancers (Basel), 12(9):2398. Italy (athymic nude mice)
    575. Gomes, AP., et al. (2020). Nature, 585(7824):283-287. North America (athymic nude mice)
    576. Gonzalez-Sanchez, L., et al. (2020). Carcinogenesis, 41(8):1113-1122. Spain (athymic nude mice)
    577. Franklin, DA., et al. (2020). JCI Insight, 5(15):e134290. North America (athymic nude mice)
    578. England, RM., et. al. (2020). Biomacromolecules, 21(8):3332-3341. UK (athymic nude mice)
    579. Gelsomino, L., et al. (2020). Cancers (Basel), 12(8):2078. Italy (athymic nude mice)
    580. Nwagwu, CD., et al. (2020). Lab Anim (NY), 49(8):227-232. North America (athymic nude mice)
    581. Yan, P., et al, (2020). Cell Rep, 31(13):107840. North America (athymic nude mice)
    582. Mohammadabadi, A., et al. (2020). Phys Med Biol, 65(12):125017. North America (athymic nude mice)
    583. Chen. Y., et al. (2020). Prostate, 80(12):993-1005. North America (athymic nude mice)
    584. Trotta, F., et al. (2020). Mol Cancer Ther, 19(9):1909-1921. Italy (athymic nude mice)
    585. Siddique, AB., et al. (2020). Nutrients, 12(6):1749. North America (athymic nude mice)
    586. Li, M., et al. (2020). Cancers (Basel),12(6):1538. North America (athymic nude mice)
    587. Rossi, SM., et al. (2020). Br J Cancer, 123(3):369-377. Ireland (athymic nude mice)
    588. Kennedy, AL., et al. (2020). Cancers (Basel), 12(5):1269. North America (athymic nude mice)
    589. Sharick, JT., et al. (2020). Front Oncol, 10:553. North America (athymic nude mice)
    590. Schregel, K., et al. (2020). Cancer Imaging, 20(1):35. North America (athymic nude mice)
    591. Pattarawat, P., et al. (2020). Br J Cancer, 123(2):226-239. North America (athymic nude mice)
    592. Gupta, K., et al. (2020). Front Oncol, 10:535. North America (athymic nude mice)
    593. Humeau, J., et al. (2020). EMBO Mol Med. 12(5):e11622. North America (athymic nude mice)
    594. Faugeroux, V., et al. (2020). Nat Commun,11(1):1884. North America (athymic nude mice)
    595. Fell, JB., et al. (2020). J Med Chem, 63(13):6679-6693. North America (athymic nude mice)
    596. Lingasamy, P., et al. (2020). Sci Rep, 10(1):5809. Estonia (athymic nude mice)
    597. Tozzi, M., et al. (2020). Cancers (Basel), 12(3):640. Denmark (athymic nude mice)
    598. Cam, M., et al. (2020). Neuro Oncol, 22(3):345-356. North America (athymic nude mice)
    599. Wang, Y., et al. (2020). J Immunother Cancer. 8(1):e000462. doi: 10.1136/jitc-2019-000462. France (athymic nude mice)
    600. Marayati, R., et al. (2020). J Pediatr Surg. 55(6):1072-1080. North America (athymic nude mice)
    601. Peddi, S., et al. (2020). Biomacromolecules. 21(3):1091-1102. North America (athymic nude mice)
    602. Bousquet Mur, E., et al. (2020). J Clin Invest, 130(2):612-624. France (athymic nude mice)
    603. Dwivedi, SKD., et al. (2020). FASEB J. 34(2):2287-2300. North America (athymic nude mice)
    604. Bhagwat, SV., et al. (2020). Mol Cancer Ther, 19(2):325-336. North America (athymic nude mice)
    605. Sinha, S., et al. (2020). Oncogene, 39(6):1231-1245. North America (athymic nude mice)
    606. Somwar, R., et al. (2020). Commun Biol. 23(1):776. North America (athymic nude mice)
    607. Domínguez, JM., et al. (2020). J Hematol Oncol. 13(1):32. Spain (athymic nude mice)
    608. Zheng, ZY., et al. (2020). Cancer Cell, 37(3):387-402.e7. North America (athymic nude mice)
    609. Hammer, S., et al. (2020). Clin Cancer Res, 26(8):1985-1996. Germany (athymic nude mice)
    610. Kenny, HA., et al. (2020). Mol Cancer Ther, 19(1):52-62. North America (athymic nude mice)
    611. Shen, JZ., Cell, 184(2):352-369.e23. North America (athymic nude mice)
    612. Rosenblum, D., et al. (2020). Sci Adv, 6(47):eabc9450. Israel (athymic nude mice)
    613. Valle, S., et al. (2020). Nat Commun, 11(1):5265. Spain (athymic nude mice)
    614. Alcalá, S., et al. (2020). Int J Mol Sci, 21(20):7437. Spain (athymic nude mice)
    615. Zhang, H., et al. (2020). Mol Imaging Biol, 22(5):1184-1196. North America (athymic nude mice)
    616. Tiwari, A., et al. (2020). Cancers (Basel), 12(10):2795. Germany (athymic nude mice)
    617. Dadwal, UC., et al.. (2020). Int J Mol Sci, 21(18):6913. North America (athymic nude mice)
    618. Mansi, R., et al. (2020). Molecules, 25(18):4155. Switzerland (athymic nude mice)
    619. Chomet, M., et al. (2020). Eur J Nucl Med Mol Imaging. doi: 10.1007/s00259-020-05002-7.
    620. Marcazzan, S., et al. (2020). Oral Dis. doi: 10.1111/odi.13592. North America (athymic nude mice)
    621. Mansi, R., et al. (2020). EJNMMI Res, 10(1):90. Switzerland (athymic nude mice)
    622. Miner, MW., et al. (2020). Mol Imaging Biol, 22(4):969-978. Finland (athymic nude mice)
    623. VanOpstall, C., et al. (2020). Elife, 9:e53600. North America (athymic nude mice)
    624. Verma, B, Wesa A. Curr Protoc Pharmacol. 89(1):e77. doi: 10.1002/cpph.77. North America (athymic nude mice)
    625. Li, M., et al. (2020). Am J Transl Res, 12(5):1862-1872. North America (athymic nude mice)
    626. Wei, SJ., et al. (2020). Cell Death Dis, 11(5):368. North America (athymic nude mice)
    627. Li, J., et al. (2020). Light Sci Appl. 9:57. doi: 10.1038/s41377-020-0295-y. Germany (athymic nude mice)
    628. Fanfone, D., et al. (2020). Biology (Basel), 9(3):53. Belgium (athymic nude mice)
    629. Medeiros, B., et al. (2020). Cancers (Basel), 12(1):172. North America (athymic nude mice)
    630. Maloney, R., et al. (2020). Methods Enzymol, 638:295-320. North America (athymic nude mice)
    631. Shivange, G.,et al. (2020). J Vis Exp, (159). doi: 10.3791/60727. North America (athymic nude mice)
    632. Shariati, M., et al. (2020). ACS Appl Mater Interfaces. 12(26):29024-29036. Belgium (athymic nude rats)
    633. Chaves, C., et al. (2020). Pharmaceutics. 12(5):399. France (athymic nude mice)
    634. Falvo, P., et al. (2020), Cancer Res, Feb 1;81(3):685-697. Italy (BALB/C)
    635. Bonavita, E., et al. (2020). Immunity, 53(6):1215-1229.e8. UK (BALB/C)
    636. Raineri, D., et al. (2020), Commun Biol, 3(1):615. Italy (BALB/C)
    637. Suurs, FV., et al. (2020). EJNMMI Res. 10(1):111. Netherlands (BALB/C)
    638. Di Tano, M., et al. (2020), Nat Commun. 11(1):2332. Italy (BALB/C)
    639. Teijeira, Á., et al. (2020). Immunity, 52(5):856-871.e8. Spain (BALB/C)
    640. Karp, NA., et al. (2020), Sci Rep, 10(1):6178. UK (BALB/C)
    641. Kranjc Brezar, S., et al. (2020). Vaccines (Basel), 8(1):135. Slovenia (BALB/C)
    642. Li, R., et al. (2020). Mol Cancer Ther 2019;18(12 Suppl):Abstract nr A016. North America (B-NDG)
    643. Vigant, F., et al. (2020). Journal for ImmunoTherapy of Cancer; 8:doi: 10.1136/jitc-2020-SITC2020.0117. North America (B-NDG)
    644. Pan, LN., et al. (2020). Cell Biol Int, doi: 10.1002/cbin.11524. China (B-NDG)
    645. Hu, Z., et al. (2020). Mol Ther Oncolytics, 17:361-370. doi: 10.1016/j.omto.2020.04.008. China (B-NDG)
    646. Liu, J., et al. (2020). JCI Insight, 5(12):e134728. doi: 10.1172/jci.insight. North America (B-NDG)
    647. Cheng, H., et al. (2020). J Immunol, ;205(6):1497-1502. doi: 10.4049/jimmunol.2000136. China (B-NDG)
    648. Lv, C., et al. (2020). Cell Mol Immunol, doi: 10.1038/s41423-020-0429-4. China (B-NDG)
    649. Tu, C., et al. (2020). Theranostics, 11(5):2364-2380. doi: 10.7150/thno.47996. China (B-NDG)
    650. Guan, L., etl al. (2020), Nan Fang Yi Ke Da Xue Xue Bao. 40(8):1200-1206. China (B-NDG)
    651. Hu, XT., et al. (2020). J Exp Clin Cancer Res, 39(1):270. China (B-NDG)
    652. Miao, JX., et al. (2020). World J Gastroenterol, 26(32):4802-4816. China (B-NDG)
    653. Somwar, R., et al. (2020). Commun Biol, 3(1):776. North America (C.B-17 SCID)
    654. Moquist, PN., et al. (2020). Mol Cancer Ther, 20(2):320-328. North America (C.B-17 SCID)
    655. Thomas, A., et al. (2020). Cancers (Basel), 12(8):2279. North America (C.B-17 SCID)
    656. Jones, RJ., et al. (2020). Front Immunol. 11:1816. North America (C.B-17 SCID)
    657. Zhou, W., et al. (2020). Nat Commun, 11(1):3811. North America (C.B-17 SCID)
    658. Jin, UH., et al. (2020). Cancers (Basel), 12(8):2097. North America (C.B-17 SCID)
    659. McKnight, BN., et al. (2020). Breast Cancer Res, 22(1):37. North America (C.B-17 SCID)
    660. Perrone, E., et al. (2020). Front Oncol, 10:118. North America (C.B-17 SCID)
    661. Lopez, S., et al. (2020). Oncotarget, 11(5):560-570. North America (C.B-17 SCID)
    662. Ghilu, S., et al. (2020). Cancer Chemother Pharmacol, 85(2):251-263. North America (C.B-17 SCID)
    663. Han, C., et al. (2020). Gynecol Oncol, 156(2):430-438. North America (C.B-17 SCID)
    664. Kang, L., et al. (2020). J Nucl Med, jnumed.120.246595. North America (C.B-17 SCID)
    665. Maloney, R., et al. (2020). Methods Enzymol, 638:295-320. North America (C.B-17 SCID)
    666. Bilger, A., et al. (2020). Viruses. 12(4):450. North America (athymic nude mice)
    667. Liapis, E., et al. (2020). Cancer Res, 80(23):5291-5304. Germany (NOD SCID)
    668. Zong, X., et al. (2020). Cancer Res, 80(20):4371-4385. North America (NOD SCID)
    669. Solimando, AG., et al. (2020). Haematologica, Apr 30. doi: 10.3324/haematol.2019.239913. North America (NOD SCID)
    670. Ronca, R., et al. (2020). Cancer Res, 80(11):2340-2354. Italy (NOD SCID)
    671. Hammer, S., et al. (2020). Clin Cancer Res, 26(8):1985-1996. Norway (NOD SCID)
    672. Gudlevičienė, Ž., et al. (2020). Medicina (Kaunas), 56(10):547. Lithuania (NOD SCID)
    673. Kan, T., et al. (2020). J Immunother Cancer, 8(2):e001010. Israel (NOD SCID)
    674. Barilani, M., et al. (2020). EBioMedicine, 57:102848. Italy (NOD SCID)
    675. Valta, M., Transl Androl Urol, 9(3):1120-1134. Finland (NOD SCID)
    676. Wei, W., et al. (2020). Adv Sci (Weinh), 7(13):1903595. China (R2G2®)
    677. Maaland, AF., et al. (2020). PLoS One, 15(3):e0230526. Norway (R2G2®)
    678. Chang, G., et al. (2020). Cancer Cell, 38(6):857-871.e7. North America (SCID/Beige)
    679. Bartnicka, JJ., et al. (2020). Metallomics, 12(10):1508-1520. UK (SCID/Beige)
    680. Gabay, M., et al. (2020). Cell Mol Neurobiol, doi: 10.1007/s10571-020-00969-1. Israel (SCID/Beige)
    681. Colon-Otero, G.,et al. (2020). ESMO Open, 5(5):e000926. doi: 10.1136/esmoopen-2020-000926. North America (SCID/Beige)
    682. Parhi, L., et al. (2020). Nat Commun, 11(1):3259. doi: 10.1038/s41467-020-16967-2. Israel (SCID/Beige)
    683. Reddy, TP., et al. (2020). Breast Cancer Res, 22(1):48. North America (SCID/Beige)
    684. De Thaye, E., et al. (2020). Sci Rep, 10(1):6688.  Belgium (SCID/Beige)
    685. Zheng, ZY., et al. (2020). Cancer Cell, 37(3):387-402.e7. North America (SCID/Beige)
    686. Ronca, R., et al. (2020). Cancer Res, 80(11):2340-2354. Italy (SCID/Beige)
    687. Serebrenik, AA., et al. (2020). Clin Cancer Res, 26(13):3397-3407. North America (SCID/Beige)
    688. Landolina, N., et al. (2020). Pharmacol Res, 158:104682. doi: 10.1016/j.phrs.2020.104682. Israel (SCID/Beige)
    689. Satpathy, S., et al. (2020). Nat Commun.11(1):532. doi: 10.1038/s41467-020-14381-2. North America (SCID/Beige)
    690. Santiago-O'Farrill, JM., et al. (2020). Cancer, 126(4):894-907. North America (SCID/Beige)
    691. Farrera-Sal, M., et al. (2020). Int J Mol Sci, 21(14):5158. Spain (SCID/Beige)
    Many factors can influence your selection of an appropriate research model. These published studies are identified to assist you in your selection. Envigo does not guarantee model performance in research studies.
    The cell line abbreviation “(PDX)” is utilized as a generic naming convention of a “Patient-derived Xenograft” in absence of a formal name by the researcher(s).

     

    Learn more
    Paul<br>Knepley, DVM, Attending Veterinarian

    Meet Paul
    Knepley, DVM

    Attending Veterinarian

    View Profile View Profile  
    Mandy<br>Horn, Scientist

    Meet Mandy
    Horn

    Scientist

    View Profile View Profile